{
  "iteration": 158,
  "question_id": "index_157",
  "results_by_threshold": {
    "0.65": {
      "detected_pairs": [
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c7",
          "thought1_idx": 2,
          "thought2_idx": 2,
          "text1": "Alternatively, maybe the wild-type and mutant can't form a proper dimer, so they're not functional. So the cell's transcription factor activity goes down, leading to a loss-of-function phenotype.\n\nOption B says protein degradation. I'm not sure if Y causes the proteins to degrade. If the mutant Y is not properly processed, maybe it gets degraded, but the wild-type might be as well if it's bound. Or perhaps the mutant doesn't interfere with degradation.",
          "text2": "Wait, why would the wild-type allele be degraded? I'm not sure. The mutation Y is dominant-negative, so it affects the wild-type's ability to function, but I don't think it causes the protein to degrade. Unless the mutant proteins aggregate and cause the cell to degrade them.\n\nOption C: Loss of dimerization and wild-type phenotype. No, because if dimerization is lost, the transcription factor can't function, so the phenotype would be a loss of function, not wild-type.\n\nOption D: Protein aggregation and loss-of-function. Aggregation might happen if the mutant proteins form faulty structures, leading to the formation of aggregates. If the proteins can't dimerize correctly, they might clump together, and the cell might degrade them. That would prevent the transcription factor from working, leading to a loss of function.",
          "score": 0.9003003835678101
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c5",
          "thought1_idx": 3,
          "thought2_idx": 2,
          "text1": "Wait, but the question is about the presence of mutation Y. So in a heterozygous state, you have some wild-type and some Y mutant proteins. The Y mutant can't form dimers, and when they try to interact with wild-type, maybe the whole complex isn't functional. So the transcription factor doesn't dimerize, doesn't go into the nucleus, and doesn't activate genes. So the phenotype is loss of function.\n\nLooking again at the options, D says protein aggregation and loss.",
          "text2": "Wait, going back. Let's think about dominant-negative mutations. In this case, the mutant Y would form a non-functional dimer when paired with wild-type. Because the dimerization domain is messed up, they can't form active dimers. So the Y mutant prevents the wild-type from functioning. So in a heterozygote, the wild-type allele is expressed but can't form active dimers because it's either binding to the mutant Y or the mutant Y is preventing the proper folding.\n\nSo the presence of Y leads to the inability of the transcription factor to dimerize, which means it can't enter the nucleus and activate gene transcription. So the phenotype would be a loss-of-function.\n\nLooking at the options, I think D says protein aggregation and loss of function. Or B says protein degradation. But I'm not sure.",
          "score": 0.9209001064300537
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c3",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Alternatively, perhaps the presence of Y causes the mutant protein to form non-functional dimers, leading to loss of function. So the dominant-negative effect is causing the loss. So looking at the options, which one matches this scenario.\n\nOption D: Aggregation and loss. I'm not sure about the aggregation part.",
          "text2": "Wait, but how does dominant-negative work? The mutant subunits might form nonfunctional dimers with wild-type subunits. So when Y is present, any wild-type subunits would pair with Y, making a dimer that can't function. So the transactivation doesn't happen, no gene expression.\n\nSo the effect is that the transcription factor can't function because the dimerization is impaired, leading to loss of function. \n\nLooking back at the options, which one fits this? Let's see:\n\nOption D says protein aggregation and loss. If Y causes the proteins to aggregate, then they're not functional, so the phenotype is loss.\n\nOption B says protein degradation. I'm not sure if Y would lead to degradation. It could, but I think dominant-negative often doesn't destroy the protein but stops it from working, perhaps by causing misfolding or improper interactions.",
          "score": 0.8802888989448547
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c6",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Wait, what's the molecular phenotype? The question says which molecular phenotype is observed. So options are about what molecular changes occur.\n\nOption D says protein aggregation and loss of function. So if the mutant Y leads to the protein aggregating, and thus not functioning, that would fit.",
          "text2": "Alternatively, perhaps the presence of Y leads to the inability of the wild-type to function. So the cells can't transcribe the gene, leading to loss of function. So the phenotype would be loss-of-function.\n\nLooking again at the options:\n\nOption B: protein degradation and loss of wild-type allele function. Not sure if degradation is a factor here.\n\nOption D: protein aggregation and loss of function. Aggregation might happen if the mutant and wild-type can't form correct dimers, so they aggregate, leading to no functional protein.\n\nSo the molecular phenotype would be that the proteins can't form dimers (so no dimerization) and the overall function is lost. So which option matches that.\n\nOption D says protein aggregation and loss of function. That makes sense. Or, if it's about dimerization, maybe option C is about loss of dimerization, but the phenotype would be loss of function, so option C is 'wild-type phenotype' which doesn't fit.",
          "score": 0.875187873840332
        },
        {
          "chain1_id": "q158_c8",
          "chain2_id": "q158_c1",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "text2": "Wait, the question is about the molecular phenotype when Y is present. So in the cell, the mutant Y protein is present. Since it\u2019s dominant-negative, when the mutant and wild-type proteins try to dimerize, they form non-functional dimers because Y is in the dimerization domain.\n\nSo the mutant Y would prevent the wild-type from dimerizing correctly. So the result is that the transcription factor can't function because the dimerization doesn't happen. So the phenotype is loss-of-function.\n\nLooking back at the options, which match this.\n\nOption D says protein aggregation and loss-of-function. I'm not sure if the proteins aggregate, but in dominant-negative situations, the mutant might interfere with the wild-type, leading to non-functional dimers. So more likely, the phenotype is loss-of-function.\n\nLooking at the options again:\n\nOption B: Protein degradation and loss of wild-type. I'm not sure about degradation. Option D says aggregation and loss.",
          "score": 0.9468410015106201
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c5",
          "thought1_idx": 7,
          "thought2_idx": 7,
          "text1": "Wait, looking at option D: 'protein aggregation and loss of function.' So the change is aggregation, but the phenotype is loss of function.",
          "text2": "Wait, the options:\n\nOption D: protein aggregation and loss of function.\n\nOption B: protein degradation and loss of function.\n\nOption C: loss of dimerization and wild-type phenotype. No, the phenotype isn't wild-type.",
          "score": 0.7663684487342834
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c2",
          "thought1_idx": 7,
          "thought2_idx": 6,
          "text1": "Alternatively, sometimes dominant-negative mutations can cause the mutant and wild-type proteins to form non-functional dimers, leading to a lack of active transcription factors.",
          "text2": "Alternatively, if the mutant proteins can't dimerize correctly, maybe they form some aggregates, leading to their degradation or inability to function.",
          "score": 0.7671834230422974
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c7",
          "thought1_idx": 8,
          "thought2_idx": 8,
          "text1": "Wait, the question says the mutation Y is in the dimerization domain and is dominant-negative. So when Y is present, even in a heterozygous state, the mutant protein interferes with the wild-type. So the wild-type allele is not expressed, or its function is blocked.\n\nIn this case, when the inactive transcription factor is phosphorylated, it should dimerize. But if Y is present, the dimerization can't happen properly, so the activated protein can't form dimers. So the dimerization is prevented, which means the transcription factor doesn't go into the nucleus, so gene transcription doesn't occur. So the function is lost.\n\nLooking at the options, which is about the molecular phenotype.\n\nOption D says protein aggregation and loss of function. So if the mutant Y subunits can't dimerize, perhaps they form aggregates or multimers that aren't functional. So the presence of Y leads to protein aggregation and the transcription factor can't function, leading to loss of function.",
          "text2": "Wait, but the question is about the molecular phenotype. So, in the presence of Y, what's happening?\n\nIf the transcription factor can't dimerize, then even if the rest of the process (phosphorylation, moving into nucleus) happens, the dimer is necessary for function. So without dimerization, the transcription factor can't function, leading to loss of function.\n\nBut looking at the options, the question is about the mutation Y's effect. So, Y is a dominant-negative in the dimerization domain. So, the presence of Y would prevent proper dimer formation, perhaps leading to the inability of the transcription factor to function.\n\nWhich option reflects this? Let's look again at the options.\n\nOption D says protein aggregation and loss of function. That would imply that the proteins are clumping together and not functioning, leading to a loss.\n\nOption B says protein degradation and loss of function of wild-type. I'm less sure about this. Degradation because of Y? Maybe the mutant Y is marked for degradation, but would that degrade the wild-type proteins too?",
          "score": 0.9459652900695801
        },
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c8",
          "thought1_idx": 8,
          "thought2_idx": 5,
          "text1": "Wait, but the question is about the presence of Y. The molecular phenotype is what happens to the proteins.\n\nIf Y is a dominant-negative, then the mutant and wild-type form non-functional dimers. So the proteins are present but not active.\n\nSo would that lead to protein degradation? Or would they just not function?\n\nIn most cases, if the protein can't fold properly, it might be targeted for degradation via the proteasome. But in the case of dominant-negative, the WT and mutant might form dimers that are not functional but are still present.",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.8568181395530701
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c5",
          "thought1_idx": 9,
          "thought2_idx": 9,
          "text1": "Alternatively, maybe the dimerization is prevented, but not necessarily aggregation. Then, the protein would remain as monomers, unable to dimerize. So without dimerization, the protein can't function. So the molecular phenotype would be loss of dimerization, leading to loss of function.",
          "text2": "Wait, none of the options directly mention dimerization. Let me check the options again.\n\nOption A: change of conformation and gain of function.\n\nOption B: protein degradation and loss of function.\n\nOption C: loss of dimerization and wild-type phenotype.\n\nOption D: protein aggregation and loss of function.\n\nHmm, none of the options directly say 'loss of dimerization and loss of function.' So perhaps the closest is D, where the protein can't form dimers, leading to aggregation.",
          "score": 0.7986297011375427
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c5",
          "thought1_idx": 10,
          "thought2_idx": 7,
          "text1": "Alternatively, perhaps when the mutant is present, the wild-type proteins can't form dimers, so they can't function, causing a loss of function. So the phenotype would be loss of function, but the proteins aren't necessarily degraded or aggregated.",
          "text2": "Wait, the options:\n\nOption D: protein aggregation and loss of function.\n\nOption B: protein degradation and loss of function.\n\nOption C: loss of dimerization and wild-type phenotype. No, the phenotype isn't wild-type.",
          "score": 0.8194751739501953
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c2",
          "thought1_idx": 10,
          "thought2_idx": 9,
          "text1": "Another angle: the wild-type allele's function being lost. If Y is dominant-negative, it inhibits the wild-type allele, making its protein unable to function. So the wild-type protein's function is lost because it's being interfered with by Y.\n\nBut if the wild-type is present but can't function due to Y, then the overall effect is loss of function, but is the protein being degraded or just non-functional?",
          "text2": "Wait, but option B is protein degradation and loss of wild-type function. That would happen if the mutant Y somehow caused the wild-type proteins to be targeted for degradation. But in dominant-negative scenarios, the proteins are usually not broken down but just non-functional.\n\nSo between options D and B. I think the key here is that the dominant-negative mutation Y would cause the wild-type proteins to be unable to function because they form non-functional dimers with Y. So the presence of Y would lead to the inability of the wild-type allele to function. However, the proteins themselves may not be degraded; they just can't form the right structures.",
          "score": 0.8717443943023682
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c4",
          "thought1_idx": 11,
          "thought2_idx": 10,
          "text1": "Wait, but the options don't have an option that just says loss of function. Let me check the options again.\n\nOptions:\n\nA) change of conformation and gain\n\nB) degradation and loss of wild-type\n\nC) loss of dimerization and wild-type (no, because if dimerization is lost, the phenotype should be loss)\n\nD) aggregation and loss.",
          "text2": "Wait, the options don't include \"loss of dimerization\" as a separate choice, but option C says \"loss of protein dimerization and wild-type phenotype\", which doesn't make sense because the function would be lost, not wild-type.\n\nHmm, perhaps I'm overcomplicating this. Let's think about what each option describes.\n\nOption D: protein aggregation and loss of function. So the protein can't dimerize properly, leading to aggregation (like inclusion bodies or something) and the function is lost.",
          "score": 0.764755368232727
        },
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c2",
          "thought1_idx": 11,
          "thought2_idx": 5,
          "text1": "Another angle: in a dominant-negative scenario, the mutant interferes with the function of the normal allele. So when the person is heterozygous (wild-type and Y), the Y allele's product (which is mutant) will interfere with the wild-type product's ability to function.\n\nSince Y is in the dimerization domain, when the two subunits try to come together, perhaps the mutant Y prevents proper dimerization. So the wild-type can't form functional dimers, leading to the inability to translocate to the nucleus and activate transcription.\n\nSo the result would be that the transcription factor doesn't function, leading to a loss of function. So the phenotype is loss of function.\n\nLooking at the options, options B, C, D have loss of function. So the question is about the molecular phenotype. What's happening to the proteins?\n\nOption D says protein aggregation and loss of function. So perhaps the proteins can't form the proper dimers and instead form aggregates.",
          "text2": "Wait, the question is about the molecular phenotype. So what's happening at the molecular level?\n\nDominant-negative mutations often lead to the formation of non-functional complexes. So the presence of Y would mean that the wild-type allele's product (the transcription factor) can't form functional dimers because they are associating with the mutant Y subunits which prevent proper dimerization.\n\nSo the wild-type proteins are present but can't function because they're stuck in non-functional dimers. The mutant Y doesn't form functional dimers on its own, but can interfere with the wild-type.\n\nSo the overall result is that the transcription factor can't function, leading to loss of gene transcription. So the phenotype would be loss-of-function.\n\nLooking at the options again:\n\nOption D says protein aggregation and loss-of-function. If the mutant prevents proper dimerization, perhaps the proteins don't aggregate but are just unable to form the correct structures.",
          "score": 0.9457690715789795
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c5",
          "thought1_idx": 12,
          "thought2_idx": 3,
          "text1": "Alternatively, perhaps the mutant Y doesn't allow proper dimerization, so the proteins can't form the correct structures, so they don't move to the nucleus, effectively making the transcription factor non-functional. So the phenotype is loss of function, but no degradation necessarily.",
          "text2": "Alternatively, without proper dimerization, maybe the proteins can't function, leading to their inability to enter the nucleus. So the result is that the gene transcription doesn't happen, leading to a loss of function.\n\nThe options:\n\nA) Gain of function: no, it's a dominant-negative, so it's loss of function.\n\nB) Protein degradation: perhaps, but the question doesn't mention anything about degradation. It's more about dimerization. So maybe not.\n\nC) Wild-type phenotype: No, the presence of Y would cause a loss of function. It says in the presence of Y, which is dominant-negative, so the phenotype would be loss of function.\n\nOption D: protein aggregation and loss of function. If the mutant Y causes the proteins to aggregate, perhaps they form insoluble clumps, which would prevent their proper function. So the proteins can't dimerize correctly and form aggregates, leading to loss of function.",
          "score": 0.8321651220321655
        },
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c1",
          "thought1_idx": 12,
          "thought2_idx": 8,
          "text1": "Alternatively, if they can't form dimers, maybe they don't aggregate but are just not functional.\n\nOption B says protein degradation. Maybe the mutant Y is subject to degradation, but the wild-type would still be present. But since the Y is dominant-negative, perhaps both alleles are affected.",
          "text2": "Alternatively, they might form non-functional dimers.\n\nLooking at the options again, which one says \"loss of function\" and some other effect.\n\nOption B: protein degradation and loss. If the mutation Y causes the proteins to be degraded, then both the mutant and wild-type might be degraded. But the scenario says it's a dominant-negative, so perhaps the mutant doesn't get degraded but prevents the wild-type from working.",
          "score": 0.8202989101409912
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c1",
          "thought1_idx": 15,
          "thought2_idx": 4,
          "text1": "Alternatively, if the dimerization is critical for nuclear import, and the mutant Y prevents this, the proteins might remain in the cytoplasm and not enter the nucleus, leading to loss of function. But this doesn't necessarily cause protein aggregation.\n\nSo perhaps the molecular phenotype is that the proteins can't dimerize, so they're stuck as monomers and can't function. So the presence of Y would lead to loss of dimerization, thus loss of function.\n\nLooking back at the options, option D involves protein aggregation, which I'm not sure about. Option B is about degradation. Option C says loss of dimerization and wild-type phenotype, which doesn't make sense because the phenotype would be loss.",
          "text2": "Alternatively, when the mutant Y is present, the normal protein can't form dimers, so they might not be able to enter the nucleus. So the transcription factor doesn't work, leading to loss of function.\n\nSo which option aligns with this?\n\nOption D says protein aggregation and loss-of-function. But does the mutant cause aggregation? Or does it just prevent dimerization?",
          "score": 0.9081236124038696
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c4",
          "thought1_idx": 16,
          "thought2_idx": 8,
          "text1": "Wait, the missense mutation Y is in the dimerization domain. So the mutant's dimerization domain is faulty. When a wild-type subunit and a Y subunit try to dimerize, they can't form a functional dimer. So the dimerization can't occur, so the protein doesn't enter the nucleus, and gene transcription doesn't happen.\n\nSo the molecular change would be the inability to dimerize. Therefore, the answer should involve loss of dimerization. Looking at the options, only option C mentions loss of dimerization, but its second part is incorrect.",
          "text2": "Wait, the question says the mutation Y is in the dimerization domain and is dominant-negative. So when Y is present, even in a heterozygous state, the mutant protein interferes with the wild-type. So the wild-type allele is not expressed, or its function is blocked.\n\nIn this case, when the inactive transcription factor is phosphorylated, it should dimerize. But if Y is present, the dimerization can't happen properly, so the activated protein can't form dimers. So the dimerization is prevented, which means the transcription factor doesn't go into the nucleus, so gene transcription doesn't occur. So the function is lost.\n\nLooking at the options, which is about the molecular phenotype.\n\nOption D says protein aggregation and loss of function. So if the mutant Y subunits can't dimerize, perhaps they form aggregates or multimers that aren't functional. So the presence of Y leads to protein aggregation and the transcription factor can't function, leading to loss of function.",
          "score": 0.8433146476745605
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c1",
          "thought1_idx": 16,
          "thought2_idx": 12,
          "text1": "Wait, but the question is about the presence of mutation Y. The key is that Y is dominant-negative, so the heterozygous state leads to the mutant allele preventing the wild-type from functioning.\n\nSo, in terms of the effect on the protein:\n\n- The mutant Y can't dimerize, so when it's present, it can't form the necessary dimers, thus the transcription factor can't function. So the phenotype is loss of function.\n\nLooking back at the options, D says protein aggregation and loss of function. This would fit if the mutant proteins aggregate, but I'm not certain.",
          "text2": "Wait, option C says loss of dimerization and wild-type phenotype. That doesn't make sense. If dimerization is lost, the phenotype can't be wild-type. So that's not correct.\n\nSo, back to the options.\n\nThe Y mutation is in the dimerization domain and is dominant-negative. So the mutant subunits would interfere with the wild-type's ability to dimerize.\n\nIn a heterozygous state, there are some wild-type and some mutant proteins.\n\nWhen the mutant proteins are present, they might form non-functional dimers with the wild-type, or perhaps prevent the wild-type from finding a partner to dimerize with.\n\nSo, the wild-type protein's ability to dimerize is blocked, so the transcription factor can't function. Thus, the phenotype is a loss of function.\n\nLooking at the options, which have a loss of function.\n\nOption B: protein degradation and loss of wild-type function.\n\nOption D: protein aggregation and loss.\n\nBut I think in dominant-negative, the proteins are present but non-functional. So no degradation, but they can't form functional dimers.\n\nSo perhaps the molecular phenotype is that the proteins can't dimerize, leading to loss of function.\n\nSo, looking for an option that says loss of dimerization and loss of function. But none of the options directly state that.",
          "score": 0.939691424369812
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c8",
          "thought1_idx": 17,
          "thought2_idx": 5,
          "text1": "Wait, but because it's a dominant-negative, the presence of Y in the cell would affect the function of the wild-type. If the Y subunits can still bind to wild-type subunits, then the resulting dimers would be non-functional. So the wild-type subunits are present but can't form functional dimers because they're stuck with the mutant Y.\n\nSo the result is that the transcription factor can't function, leading to loss of function.\n\nSo the molecular phenotype would involve the inability to dimerize, leading to loss of function. But looking at the options, none of them directly say that. The options are about the proteins\u2014either their conformation, aggregation, degradation, etc.\n\nIn the presence of Y, the proteins can't form dimers, so they don't perform their function. But what about their presence in the cell? Do they aggregate?",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.9297323226928711
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c8",
          "thought1_idx": 19,
          "thought2_idx": 2,
          "text1": "Alternatively, the mutant Y could cause the entire complex to be non-functional, leading to the protein not being active, but perhaps the proteins are still present.\n\nSo, the dominant-negative effect would mean that the presence of Y prevents the normal function of the transcription factor. So the outcome is that the transcription factor can't function, leading to loss of function.\n\nWhich options have loss of function? A is gain, so no. B and D are loss. C is wild-type.\n\nSo between B and D.\n\nOption B: protein degradation and loss of wild-type. So, the mutant Y's protein is being degraded, perhaps due to misfolding. But would that affect the wild-type? Maybe not directly. But if the mutant Y is causing the wild-type proteins to be unable to form dimers, perhaps the wild-type proteins are stuck in the cytoplasm and get degraded.",
          "text2": "Wait, but what's the effect of dominant-negative in this case? The mutant Y would interfere with the dimerization of the wild-type. So the presence of Y would mean that even the wild-type subunits can't form active dimers because they pair with the mutant Y, which can't form proper dimers. So the result is that the transcription factor doesn't function, leading to a loss of function.\n\nLooking back at the options, in D, the proteins aggregate and function is lost.",
          "score": 0.916894257068634
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c3",
          "thought1_idx": 22,
          "thought2_idx": 3,
          "text1": "Wait, another angle: when a protein is dominant-negative, it often means that it interferes with the normal function of the wild-type protein. So, in this case, the Y mutant might form non-functional dimers with the wild-type, preventing them from functioning. So the overall effect is that the transcription factor can't function, leading to loss of function.\n\nBut the question is about the molecular phenotype. So, what's happening at the molecular level?\n\nOption D says protein aggregation and loss of function.",
          "text2": "Wait, but how does dominant-negative work? The mutant subunits might form nonfunctional dimers with wild-type subunits. So when Y is present, any wild-type subunits would pair with Y, making a dimer that can't function. So the transactivation doesn't happen, no gene expression.\n\nSo the effect is that the transcription factor can't function because the dimerization is impaired, leading to loss of function. \n\nLooking back at the options, which one fits this? Let's see:\n\nOption D says protein aggregation and loss. If Y causes the proteins to aggregate, then they're not functional, so the phenotype is loss.\n\nOption B says protein degradation. I'm not sure if Y would lead to degradation. It could, but I think dominant-negative often doesn't destroy the protein but stops it from working, perhaps by causing misfolding or improper interactions.",
          "score": 0.9446625113487244
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c8",
          "thought1_idx": 26,
          "thought2_idx": 5,
          "text1": "Alternatively, perhaps the dominant-negative Y causes the mutant protein to aggregate, leading to the loss of function. So the molecular change is aggregation, and the phenotype is loss of function. That would make option D correct.\n\nBut I'm not sure if aggregation is the correct molecular change. Maybe the presence of Y doesn't cause the proteins to aggregate but just prevents dimerization.",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.8950203061103821
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c6",
          "thought1_idx": 30,
          "thought2_idx": 5,
          "text1": "Alternatively, perhaps the answer is D. Because when a dominant-negative mutation is present, the mutant proteins can interfere with the wild-type, perhaps leading to the formation of aggregates (misfolded proteins) which can't function, thus leading to loss of function.\n\nSo in that case, the molecular phenotype would involve aggregation, making option D correct.",
          "text2": "Another approach: dominant-negative in the dimerization domain. When a dominant-negative mutation is present, the mutant protein can't function on its own, but can disrupt the function of the wild-type protein.\n\nSo for example, suppose the protein normally forms homo-dimers. If one subunit is mutant Y, it can't form a proper dimer. If the mutant Y binds to the wild-type, it might form a hetero-dimer that doesn't function. So the presence of Y would mean that even when the wild-type is present, the overall activity is reduced because many of the dimers are non-functional.\n\nIn this case, dimerization is affected, leading to a loss of function. So the molecular phenotype would be that the proteins can't dimerize (so loss of dimerization) and the phenotype is loss of function.\n\nLooking at the options again:\n\nOption D: protein aggregation and loss of function. So if the proteins can't dimerize, they might form aggregates? Or perhaps the mutant is not properly folded and aggregates.",
          "score": 0.8662033081054688
        }
      ],
      "num_detected": 24,
      "num_same_answer": 24,
      "same_answer_perc": 100.0
    },
    "0.7": {
      "detected_pairs": [
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c7",
          "thought1_idx": 2,
          "thought2_idx": 2,
          "text1": "Alternatively, maybe the wild-type and mutant can't form a proper dimer, so they're not functional. So the cell's transcription factor activity goes down, leading to a loss-of-function phenotype.\n\nOption B says protein degradation. I'm not sure if Y causes the proteins to degrade. If the mutant Y is not properly processed, maybe it gets degraded, but the wild-type might be as well if it's bound. Or perhaps the mutant doesn't interfere with degradation.",
          "text2": "Wait, why would the wild-type allele be degraded? I'm not sure. The mutation Y is dominant-negative, so it affects the wild-type's ability to function, but I don't think it causes the protein to degrade. Unless the mutant proteins aggregate and cause the cell to degrade them.\n\nOption C: Loss of dimerization and wild-type phenotype. No, because if dimerization is lost, the transcription factor can't function, so the phenotype would be a loss of function, not wild-type.\n\nOption D: Protein aggregation and loss-of-function. Aggregation might happen if the mutant proteins form faulty structures, leading to the formation of aggregates. If the proteins can't dimerize correctly, they might clump together, and the cell might degrade them. That would prevent the transcription factor from working, leading to a loss of function.",
          "score": 0.9003003835678101
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c5",
          "thought1_idx": 3,
          "thought2_idx": 2,
          "text1": "Wait, but the question is about the presence of mutation Y. So in a heterozygous state, you have some wild-type and some Y mutant proteins. The Y mutant can't form dimers, and when they try to interact with wild-type, maybe the whole complex isn't functional. So the transcription factor doesn't dimerize, doesn't go into the nucleus, and doesn't activate genes. So the phenotype is loss of function.\n\nLooking again at the options, D says protein aggregation and loss.",
          "text2": "Wait, going back. Let's think about dominant-negative mutations. In this case, the mutant Y would form a non-functional dimer when paired with wild-type. Because the dimerization domain is messed up, they can't form active dimers. So the Y mutant prevents the wild-type from functioning. So in a heterozygote, the wild-type allele is expressed but can't form active dimers because it's either binding to the mutant Y or the mutant Y is preventing the proper folding.\n\nSo the presence of Y leads to the inability of the transcription factor to dimerize, which means it can't enter the nucleus and activate gene transcription. So the phenotype would be a loss-of-function.\n\nLooking at the options, I think D says protein aggregation and loss of function. Or B says protein degradation. But I'm not sure.",
          "score": 0.9209001064300537
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c3",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Alternatively, perhaps the presence of Y causes the mutant protein to form non-functional dimers, leading to loss of function. So the dominant-negative effect is causing the loss. So looking at the options, which one matches this scenario.\n\nOption D: Aggregation and loss. I'm not sure about the aggregation part.",
          "text2": "Wait, but how does dominant-negative work? The mutant subunits might form nonfunctional dimers with wild-type subunits. So when Y is present, any wild-type subunits would pair with Y, making a dimer that can't function. So the transactivation doesn't happen, no gene expression.\n\nSo the effect is that the transcription factor can't function because the dimerization is impaired, leading to loss of function. \n\nLooking back at the options, which one fits this? Let's see:\n\nOption D says protein aggregation and loss. If Y causes the proteins to aggregate, then they're not functional, so the phenotype is loss.\n\nOption B says protein degradation. I'm not sure if Y would lead to degradation. It could, but I think dominant-negative often doesn't destroy the protein but stops it from working, perhaps by causing misfolding or improper interactions.",
          "score": 0.8802888989448547
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c6",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Wait, what's the molecular phenotype? The question says which molecular phenotype is observed. So options are about what molecular changes occur.\n\nOption D says protein aggregation and loss of function. So if the mutant Y leads to the protein aggregating, and thus not functioning, that would fit.",
          "text2": "Alternatively, perhaps the presence of Y leads to the inability of the wild-type to function. So the cells can't transcribe the gene, leading to loss of function. So the phenotype would be loss-of-function.\n\nLooking again at the options:\n\nOption B: protein degradation and loss of wild-type allele function. Not sure if degradation is a factor here.\n\nOption D: protein aggregation and loss of function. Aggregation might happen if the mutant and wild-type can't form correct dimers, so they aggregate, leading to no functional protein.\n\nSo the molecular phenotype would be that the proteins can't form dimers (so no dimerization) and the overall function is lost. So which option matches that.\n\nOption D says protein aggregation and loss of function. That makes sense. Or, if it's about dimerization, maybe option C is about loss of dimerization, but the phenotype would be loss of function, so option C is 'wild-type phenotype' which doesn't fit.",
          "score": 0.875187873840332
        },
        {
          "chain1_id": "q158_c8",
          "chain2_id": "q158_c1",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "text2": "Wait, the question is about the molecular phenotype when Y is present. So in the cell, the mutant Y protein is present. Since it\u2019s dominant-negative, when the mutant and wild-type proteins try to dimerize, they form non-functional dimers because Y is in the dimerization domain.\n\nSo the mutant Y would prevent the wild-type from dimerizing correctly. So the result is that the transcription factor can't function because the dimerization doesn't happen. So the phenotype is loss-of-function.\n\nLooking back at the options, which match this.\n\nOption D says protein aggregation and loss-of-function. I'm not sure if the proteins aggregate, but in dominant-negative situations, the mutant might interfere with the wild-type, leading to non-functional dimers. So more likely, the phenotype is loss-of-function.\n\nLooking at the options again:\n\nOption B: Protein degradation and loss of wild-type. I'm not sure about degradation. Option D says aggregation and loss.",
          "score": 0.9468410015106201
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c5",
          "thought1_idx": 7,
          "thought2_idx": 7,
          "text1": "Wait, looking at option D: 'protein aggregation and loss of function.' So the change is aggregation, but the phenotype is loss of function.",
          "text2": "Wait, the options:\n\nOption D: protein aggregation and loss of function.\n\nOption B: protein degradation and loss of function.\n\nOption C: loss of dimerization and wild-type phenotype. No, the phenotype isn't wild-type.",
          "score": 0.7663684487342834
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c2",
          "thought1_idx": 7,
          "thought2_idx": 6,
          "text1": "Alternatively, sometimes dominant-negative mutations can cause the mutant and wild-type proteins to form non-functional dimers, leading to a lack of active transcription factors.",
          "text2": "Alternatively, if the mutant proteins can't dimerize correctly, maybe they form some aggregates, leading to their degradation or inability to function.",
          "score": 0.7671834230422974
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c7",
          "thought1_idx": 8,
          "thought2_idx": 8,
          "text1": "Wait, the question says the mutation Y is in the dimerization domain and is dominant-negative. So when Y is present, even in a heterozygous state, the mutant protein interferes with the wild-type. So the wild-type allele is not expressed, or its function is blocked.\n\nIn this case, when the inactive transcription factor is phosphorylated, it should dimerize. But if Y is present, the dimerization can't happen properly, so the activated protein can't form dimers. So the dimerization is prevented, which means the transcription factor doesn't go into the nucleus, so gene transcription doesn't occur. So the function is lost.\n\nLooking at the options, which is about the molecular phenotype.\n\nOption D says protein aggregation and loss of function. So if the mutant Y subunits can't dimerize, perhaps they form aggregates or multimers that aren't functional. So the presence of Y leads to protein aggregation and the transcription factor can't function, leading to loss of function.",
          "text2": "Wait, but the question is about the molecular phenotype. So, in the presence of Y, what's happening?\n\nIf the transcription factor can't dimerize, then even if the rest of the process (phosphorylation, moving into nucleus) happens, the dimer is necessary for function. So without dimerization, the transcription factor can't function, leading to loss of function.\n\nBut looking at the options, the question is about the mutation Y's effect. So, Y is a dominant-negative in the dimerization domain. So, the presence of Y would prevent proper dimer formation, perhaps leading to the inability of the transcription factor to function.\n\nWhich option reflects this? Let's look again at the options.\n\nOption D says protein aggregation and loss of function. That would imply that the proteins are clumping together and not functioning, leading to a loss.\n\nOption B says protein degradation and loss of function of wild-type. I'm less sure about this. Degradation because of Y? Maybe the mutant Y is marked for degradation, but would that degrade the wild-type proteins too?",
          "score": 0.9459652900695801
        },
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c8",
          "thought1_idx": 8,
          "thought2_idx": 5,
          "text1": "Wait, but the question is about the presence of Y. The molecular phenotype is what happens to the proteins.\n\nIf Y is a dominant-negative, then the mutant and wild-type form non-functional dimers. So the proteins are present but not active.\n\nSo would that lead to protein degradation? Or would they just not function?\n\nIn most cases, if the protein can't fold properly, it might be targeted for degradation via the proteasome. But in the case of dominant-negative, the WT and mutant might form dimers that are not functional but are still present.",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.8568181395530701
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c5",
          "thought1_idx": 9,
          "thought2_idx": 9,
          "text1": "Alternatively, maybe the dimerization is prevented, but not necessarily aggregation. Then, the protein would remain as monomers, unable to dimerize. So without dimerization, the protein can't function. So the molecular phenotype would be loss of dimerization, leading to loss of function.",
          "text2": "Wait, none of the options directly mention dimerization. Let me check the options again.\n\nOption A: change of conformation and gain of function.\n\nOption B: protein degradation and loss of function.\n\nOption C: loss of dimerization and wild-type phenotype.\n\nOption D: protein aggregation and loss of function.\n\nHmm, none of the options directly say 'loss of dimerization and loss of function.' So perhaps the closest is D, where the protein can't form dimers, leading to aggregation.",
          "score": 0.7986297011375427
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c5",
          "thought1_idx": 10,
          "thought2_idx": 7,
          "text1": "Alternatively, perhaps when the mutant is present, the wild-type proteins can't form dimers, so they can't function, causing a loss of function. So the phenotype would be loss of function, but the proteins aren't necessarily degraded or aggregated.",
          "text2": "Wait, the options:\n\nOption D: protein aggregation and loss of function.\n\nOption B: protein degradation and loss of function.\n\nOption C: loss of dimerization and wild-type phenotype. No, the phenotype isn't wild-type.",
          "score": 0.8194751739501953
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c2",
          "thought1_idx": 10,
          "thought2_idx": 9,
          "text1": "Another angle: the wild-type allele's function being lost. If Y is dominant-negative, it inhibits the wild-type allele, making its protein unable to function. So the wild-type protein's function is lost because it's being interfered with by Y.\n\nBut if the wild-type is present but can't function due to Y, then the overall effect is loss of function, but is the protein being degraded or just non-functional?",
          "text2": "Wait, but option B is protein degradation and loss of wild-type function. That would happen if the mutant Y somehow caused the wild-type proteins to be targeted for degradation. But in dominant-negative scenarios, the proteins are usually not broken down but just non-functional.\n\nSo between options D and B. I think the key here is that the dominant-negative mutation Y would cause the wild-type proteins to be unable to function because they form non-functional dimers with Y. So the presence of Y would lead to the inability of the wild-type allele to function. However, the proteins themselves may not be degraded; they just can't form the right structures.",
          "score": 0.8717443943023682
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c4",
          "thought1_idx": 11,
          "thought2_idx": 10,
          "text1": "Wait, but the options don't have an option that just says loss of function. Let me check the options again.\n\nOptions:\n\nA) change of conformation and gain\n\nB) degradation and loss of wild-type\n\nC) loss of dimerization and wild-type (no, because if dimerization is lost, the phenotype should be loss)\n\nD) aggregation and loss.",
          "text2": "Wait, the options don't include \"loss of dimerization\" as a separate choice, but option C says \"loss of protein dimerization and wild-type phenotype\", which doesn't make sense because the function would be lost, not wild-type.\n\nHmm, perhaps I'm overcomplicating this. Let's think about what each option describes.\n\nOption D: protein aggregation and loss of function. So the protein can't dimerize properly, leading to aggregation (like inclusion bodies or something) and the function is lost.",
          "score": 0.764755368232727
        },
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c2",
          "thought1_idx": 11,
          "thought2_idx": 5,
          "text1": "Another angle: in a dominant-negative scenario, the mutant interferes with the function of the normal allele. So when the person is heterozygous (wild-type and Y), the Y allele's product (which is mutant) will interfere with the wild-type product's ability to function.\n\nSince Y is in the dimerization domain, when the two subunits try to come together, perhaps the mutant Y prevents proper dimerization. So the wild-type can't form functional dimers, leading to the inability to translocate to the nucleus and activate transcription.\n\nSo the result would be that the transcription factor doesn't function, leading to a loss of function. So the phenotype is loss of function.\n\nLooking at the options, options B, C, D have loss of function. So the question is about the molecular phenotype. What's happening to the proteins?\n\nOption D says protein aggregation and loss of function. So perhaps the proteins can't form the proper dimers and instead form aggregates.",
          "text2": "Wait, the question is about the molecular phenotype. So what's happening at the molecular level?\n\nDominant-negative mutations often lead to the formation of non-functional complexes. So the presence of Y would mean that the wild-type allele's product (the transcription factor) can't form functional dimers because they are associating with the mutant Y subunits which prevent proper dimerization.\n\nSo the wild-type proteins are present but can't function because they're stuck in non-functional dimers. The mutant Y doesn't form functional dimers on its own, but can interfere with the wild-type.\n\nSo the overall result is that the transcription factor can't function, leading to loss of gene transcription. So the phenotype would be loss-of-function.\n\nLooking at the options again:\n\nOption D says protein aggregation and loss-of-function. If the mutant prevents proper dimerization, perhaps the proteins don't aggregate but are just unable to form the correct structures.",
          "score": 0.9457690715789795
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c5",
          "thought1_idx": 12,
          "thought2_idx": 3,
          "text1": "Alternatively, perhaps the mutant Y doesn't allow proper dimerization, so the proteins can't form the correct structures, so they don't move to the nucleus, effectively making the transcription factor non-functional. So the phenotype is loss of function, but no degradation necessarily.",
          "text2": "Alternatively, without proper dimerization, maybe the proteins can't function, leading to their inability to enter the nucleus. So the result is that the gene transcription doesn't happen, leading to a loss of function.\n\nThe options:\n\nA) Gain of function: no, it's a dominant-negative, so it's loss of function.\n\nB) Protein degradation: perhaps, but the question doesn't mention anything about degradation. It's more about dimerization. So maybe not.\n\nC) Wild-type phenotype: No, the presence of Y would cause a loss of function. It says in the presence of Y, which is dominant-negative, so the phenotype would be loss of function.\n\nOption D: protein aggregation and loss of function. If the mutant Y causes the proteins to aggregate, perhaps they form insoluble clumps, which would prevent their proper function. So the proteins can't dimerize correctly and form aggregates, leading to loss of function.",
          "score": 0.8321651220321655
        },
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c1",
          "thought1_idx": 12,
          "thought2_idx": 8,
          "text1": "Alternatively, if they can't form dimers, maybe they don't aggregate but are just not functional.\n\nOption B says protein degradation. Maybe the mutant Y is subject to degradation, but the wild-type would still be present. But since the Y is dominant-negative, perhaps both alleles are affected.",
          "text2": "Alternatively, they might form non-functional dimers.\n\nLooking at the options again, which one says \"loss of function\" and some other effect.\n\nOption B: protein degradation and loss. If the mutation Y causes the proteins to be degraded, then both the mutant and wild-type might be degraded. But the scenario says it's a dominant-negative, so perhaps the mutant doesn't get degraded but prevents the wild-type from working.",
          "score": 0.8202989101409912
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c1",
          "thought1_idx": 15,
          "thought2_idx": 4,
          "text1": "Alternatively, if the dimerization is critical for nuclear import, and the mutant Y prevents this, the proteins might remain in the cytoplasm and not enter the nucleus, leading to loss of function. But this doesn't necessarily cause protein aggregation.\n\nSo perhaps the molecular phenotype is that the proteins can't dimerize, so they're stuck as monomers and can't function. So the presence of Y would lead to loss of dimerization, thus loss of function.\n\nLooking back at the options, option D involves protein aggregation, which I'm not sure about. Option B is about degradation. Option C says loss of dimerization and wild-type phenotype, which doesn't make sense because the phenotype would be loss.",
          "text2": "Alternatively, when the mutant Y is present, the normal protein can't form dimers, so they might not be able to enter the nucleus. So the transcription factor doesn't work, leading to loss of function.\n\nSo which option aligns with this?\n\nOption D says protein aggregation and loss-of-function. But does the mutant cause aggregation? Or does it just prevent dimerization?",
          "score": 0.9081236124038696
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c4",
          "thought1_idx": 16,
          "thought2_idx": 8,
          "text1": "Wait, the missense mutation Y is in the dimerization domain. So the mutant's dimerization domain is faulty. When a wild-type subunit and a Y subunit try to dimerize, they can't form a functional dimer. So the dimerization can't occur, so the protein doesn't enter the nucleus, and gene transcription doesn't happen.\n\nSo the molecular change would be the inability to dimerize. Therefore, the answer should involve loss of dimerization. Looking at the options, only option C mentions loss of dimerization, but its second part is incorrect.",
          "text2": "Wait, the question says the mutation Y is in the dimerization domain and is dominant-negative. So when Y is present, even in a heterozygous state, the mutant protein interferes with the wild-type. So the wild-type allele is not expressed, or its function is blocked.\n\nIn this case, when the inactive transcription factor is phosphorylated, it should dimerize. But if Y is present, the dimerization can't happen properly, so the activated protein can't form dimers. So the dimerization is prevented, which means the transcription factor doesn't go into the nucleus, so gene transcription doesn't occur. So the function is lost.\n\nLooking at the options, which is about the molecular phenotype.\n\nOption D says protein aggregation and loss of function. So if the mutant Y subunits can't dimerize, perhaps they form aggregates or multimers that aren't functional. So the presence of Y leads to protein aggregation and the transcription factor can't function, leading to loss of function.",
          "score": 0.8433146476745605
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c1",
          "thought1_idx": 16,
          "thought2_idx": 12,
          "text1": "Wait, but the question is about the presence of mutation Y. The key is that Y is dominant-negative, so the heterozygous state leads to the mutant allele preventing the wild-type from functioning.\n\nSo, in terms of the effect on the protein:\n\n- The mutant Y can't dimerize, so when it's present, it can't form the necessary dimers, thus the transcription factor can't function. So the phenotype is loss of function.\n\nLooking back at the options, D says protein aggregation and loss of function. This would fit if the mutant proteins aggregate, but I'm not certain.",
          "text2": "Wait, option C says loss of dimerization and wild-type phenotype. That doesn't make sense. If dimerization is lost, the phenotype can't be wild-type. So that's not correct.\n\nSo, back to the options.\n\nThe Y mutation is in the dimerization domain and is dominant-negative. So the mutant subunits would interfere with the wild-type's ability to dimerize.\n\nIn a heterozygous state, there are some wild-type and some mutant proteins.\n\nWhen the mutant proteins are present, they might form non-functional dimers with the wild-type, or perhaps prevent the wild-type from finding a partner to dimerize with.\n\nSo, the wild-type protein's ability to dimerize is blocked, so the transcription factor can't function. Thus, the phenotype is a loss of function.\n\nLooking at the options, which have a loss of function.\n\nOption B: protein degradation and loss of wild-type function.\n\nOption D: protein aggregation and loss.\n\nBut I think in dominant-negative, the proteins are present but non-functional. So no degradation, but they can't form functional dimers.\n\nSo perhaps the molecular phenotype is that the proteins can't dimerize, leading to loss of function.\n\nSo, looking for an option that says loss of dimerization and loss of function. But none of the options directly state that.",
          "score": 0.939691424369812
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c8",
          "thought1_idx": 17,
          "thought2_idx": 5,
          "text1": "Wait, but because it's a dominant-negative, the presence of Y in the cell would affect the function of the wild-type. If the Y subunits can still bind to wild-type subunits, then the resulting dimers would be non-functional. So the wild-type subunits are present but can't form functional dimers because they're stuck with the mutant Y.\n\nSo the result is that the transcription factor can't function, leading to loss of function.\n\nSo the molecular phenotype would involve the inability to dimerize, leading to loss of function. But looking at the options, none of them directly say that. The options are about the proteins\u2014either their conformation, aggregation, degradation, etc.\n\nIn the presence of Y, the proteins can't form dimers, so they don't perform their function. But what about their presence in the cell? Do they aggregate?",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.9297323226928711
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c8",
          "thought1_idx": 19,
          "thought2_idx": 2,
          "text1": "Alternatively, the mutant Y could cause the entire complex to be non-functional, leading to the protein not being active, but perhaps the proteins are still present.\n\nSo, the dominant-negative effect would mean that the presence of Y prevents the normal function of the transcription factor. So the outcome is that the transcription factor can't function, leading to loss of function.\n\nWhich options have loss of function? A is gain, so no. B and D are loss. C is wild-type.\n\nSo between B and D.\n\nOption B: protein degradation and loss of wild-type. So, the mutant Y's protein is being degraded, perhaps due to misfolding. But would that affect the wild-type? Maybe not directly. But if the mutant Y is causing the wild-type proteins to be unable to form dimers, perhaps the wild-type proteins are stuck in the cytoplasm and get degraded.",
          "text2": "Wait, but what's the effect of dominant-negative in this case? The mutant Y would interfere with the dimerization of the wild-type. So the presence of Y would mean that even the wild-type subunits can't form active dimers because they pair with the mutant Y, which can't form proper dimers. So the result is that the transcription factor doesn't function, leading to a loss of function.\n\nLooking back at the options, in D, the proteins aggregate and function is lost.",
          "score": 0.916894257068634
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c3",
          "thought1_idx": 22,
          "thought2_idx": 3,
          "text1": "Wait, another angle: when a protein is dominant-negative, it often means that it interferes with the normal function of the wild-type protein. So, in this case, the Y mutant might form non-functional dimers with the wild-type, preventing them from functioning. So the overall effect is that the transcription factor can't function, leading to loss of function.\n\nBut the question is about the molecular phenotype. So, what's happening at the molecular level?\n\nOption D says protein aggregation and loss of function.",
          "text2": "Wait, but how does dominant-negative work? The mutant subunits might form nonfunctional dimers with wild-type subunits. So when Y is present, any wild-type subunits would pair with Y, making a dimer that can't function. So the transactivation doesn't happen, no gene expression.\n\nSo the effect is that the transcription factor can't function because the dimerization is impaired, leading to loss of function. \n\nLooking back at the options, which one fits this? Let's see:\n\nOption D says protein aggregation and loss. If Y causes the proteins to aggregate, then they're not functional, so the phenotype is loss.\n\nOption B says protein degradation. I'm not sure if Y would lead to degradation. It could, but I think dominant-negative often doesn't destroy the protein but stops it from working, perhaps by causing misfolding or improper interactions.",
          "score": 0.9446625113487244
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c8",
          "thought1_idx": 26,
          "thought2_idx": 5,
          "text1": "Alternatively, perhaps the dominant-negative Y causes the mutant protein to aggregate, leading to the loss of function. So the molecular change is aggregation, and the phenotype is loss of function. That would make option D correct.\n\nBut I'm not sure if aggregation is the correct molecular change. Maybe the presence of Y doesn't cause the proteins to aggregate but just prevents dimerization.",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.8950203061103821
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c6",
          "thought1_idx": 30,
          "thought2_idx": 5,
          "text1": "Alternatively, perhaps the answer is D. Because when a dominant-negative mutation is present, the mutant proteins can interfere with the wild-type, perhaps leading to the formation of aggregates (misfolded proteins) which can't function, thus leading to loss of function.\n\nSo in that case, the molecular phenotype would involve aggregation, making option D correct.",
          "text2": "Another approach: dominant-negative in the dimerization domain. When a dominant-negative mutation is present, the mutant protein can't function on its own, but can disrupt the function of the wild-type protein.\n\nSo for example, suppose the protein normally forms homo-dimers. If one subunit is mutant Y, it can't form a proper dimer. If the mutant Y binds to the wild-type, it might form a hetero-dimer that doesn't function. So the presence of Y would mean that even when the wild-type is present, the overall activity is reduced because many of the dimers are non-functional.\n\nIn this case, dimerization is affected, leading to a loss of function. So the molecular phenotype would be that the proteins can't dimerize (so loss of dimerization) and the phenotype is loss of function.\n\nLooking at the options again:\n\nOption D: protein aggregation and loss of function. So if the proteins can't dimerize, they might form aggregates? Or perhaps the mutant is not properly folded and aggregates.",
          "score": 0.8662033081054688
        }
      ],
      "num_detected": 24,
      "num_same_answer": 24,
      "same_answer_perc": 100.0
    },
    "0.75": {
      "detected_pairs": [
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c7",
          "thought1_idx": 2,
          "thought2_idx": 2,
          "text1": "Alternatively, maybe the wild-type and mutant can't form a proper dimer, so they're not functional. So the cell's transcription factor activity goes down, leading to a loss-of-function phenotype.\n\nOption B says protein degradation. I'm not sure if Y causes the proteins to degrade. If the mutant Y is not properly processed, maybe it gets degraded, but the wild-type might be as well if it's bound. Or perhaps the mutant doesn't interfere with degradation.",
          "text2": "Wait, why would the wild-type allele be degraded? I'm not sure. The mutation Y is dominant-negative, so it affects the wild-type's ability to function, but I don't think it causes the protein to degrade. Unless the mutant proteins aggregate and cause the cell to degrade them.\n\nOption C: Loss of dimerization and wild-type phenotype. No, because if dimerization is lost, the transcription factor can't function, so the phenotype would be a loss of function, not wild-type.\n\nOption D: Protein aggregation and loss-of-function. Aggregation might happen if the mutant proteins form faulty structures, leading to the formation of aggregates. If the proteins can't dimerize correctly, they might clump together, and the cell might degrade them. That would prevent the transcription factor from working, leading to a loss of function.",
          "score": 0.9003003835678101
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c5",
          "thought1_idx": 3,
          "thought2_idx": 2,
          "text1": "Wait, but the question is about the presence of mutation Y. So in a heterozygous state, you have some wild-type and some Y mutant proteins. The Y mutant can't form dimers, and when they try to interact with wild-type, maybe the whole complex isn't functional. So the transcription factor doesn't dimerize, doesn't go into the nucleus, and doesn't activate genes. So the phenotype is loss of function.\n\nLooking again at the options, D says protein aggregation and loss.",
          "text2": "Wait, going back. Let's think about dominant-negative mutations. In this case, the mutant Y would form a non-functional dimer when paired with wild-type. Because the dimerization domain is messed up, they can't form active dimers. So the Y mutant prevents the wild-type from functioning. So in a heterozygote, the wild-type allele is expressed but can't form active dimers because it's either binding to the mutant Y or the mutant Y is preventing the proper folding.\n\nSo the presence of Y leads to the inability of the transcription factor to dimerize, which means it can't enter the nucleus and activate gene transcription. So the phenotype would be a loss-of-function.\n\nLooking at the options, I think D says protein aggregation and loss of function. Or B says protein degradation. But I'm not sure.",
          "score": 0.9209001064300537
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c3",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Alternatively, perhaps the presence of Y causes the mutant protein to form non-functional dimers, leading to loss of function. So the dominant-negative effect is causing the loss. So looking at the options, which one matches this scenario.\n\nOption D: Aggregation and loss. I'm not sure about the aggregation part.",
          "text2": "Wait, but how does dominant-negative work? The mutant subunits might form nonfunctional dimers with wild-type subunits. So when Y is present, any wild-type subunits would pair with Y, making a dimer that can't function. So the transactivation doesn't happen, no gene expression.\n\nSo the effect is that the transcription factor can't function because the dimerization is impaired, leading to loss of function. \n\nLooking back at the options, which one fits this? Let's see:\n\nOption D says protein aggregation and loss. If Y causes the proteins to aggregate, then they're not functional, so the phenotype is loss.\n\nOption B says protein degradation. I'm not sure if Y would lead to degradation. It could, but I think dominant-negative often doesn't destroy the protein but stops it from working, perhaps by causing misfolding or improper interactions.",
          "score": 0.8802888989448547
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c6",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Wait, what's the molecular phenotype? The question says which molecular phenotype is observed. So options are about what molecular changes occur.\n\nOption D says protein aggregation and loss of function. So if the mutant Y leads to the protein aggregating, and thus not functioning, that would fit.",
          "text2": "Alternatively, perhaps the presence of Y leads to the inability of the wild-type to function. So the cells can't transcribe the gene, leading to loss of function. So the phenotype would be loss-of-function.\n\nLooking again at the options:\n\nOption B: protein degradation and loss of wild-type allele function. Not sure if degradation is a factor here.\n\nOption D: protein aggregation and loss of function. Aggregation might happen if the mutant and wild-type can't form correct dimers, so they aggregate, leading to no functional protein.\n\nSo the molecular phenotype would be that the proteins can't form dimers (so no dimerization) and the overall function is lost. So which option matches that.\n\nOption D says protein aggregation and loss of function. That makes sense. Or, if it's about dimerization, maybe option C is about loss of dimerization, but the phenotype would be loss of function, so option C is 'wild-type phenotype' which doesn't fit.",
          "score": 0.875187873840332
        },
        {
          "chain1_id": "q158_c8",
          "chain2_id": "q158_c1",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "text2": "Wait, the question is about the molecular phenotype when Y is present. So in the cell, the mutant Y protein is present. Since it\u2019s dominant-negative, when the mutant and wild-type proteins try to dimerize, they form non-functional dimers because Y is in the dimerization domain.\n\nSo the mutant Y would prevent the wild-type from dimerizing correctly. So the result is that the transcription factor can't function because the dimerization doesn't happen. So the phenotype is loss-of-function.\n\nLooking back at the options, which match this.\n\nOption D says protein aggregation and loss-of-function. I'm not sure if the proteins aggregate, but in dominant-negative situations, the mutant might interfere with the wild-type, leading to non-functional dimers. So more likely, the phenotype is loss-of-function.\n\nLooking at the options again:\n\nOption B: Protein degradation and loss of wild-type. I'm not sure about degradation. Option D says aggregation and loss.",
          "score": 0.9468410015106201
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c5",
          "thought1_idx": 7,
          "thought2_idx": 7,
          "text1": "Wait, looking at option D: 'protein aggregation and loss of function.' So the change is aggregation, but the phenotype is loss of function.",
          "text2": "Wait, the options:\n\nOption D: protein aggregation and loss of function.\n\nOption B: protein degradation and loss of function.\n\nOption C: loss of dimerization and wild-type phenotype. No, the phenotype isn't wild-type.",
          "score": 0.7663684487342834
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c2",
          "thought1_idx": 7,
          "thought2_idx": 6,
          "text1": "Alternatively, sometimes dominant-negative mutations can cause the mutant and wild-type proteins to form non-functional dimers, leading to a lack of active transcription factors.",
          "text2": "Alternatively, if the mutant proteins can't dimerize correctly, maybe they form some aggregates, leading to their degradation or inability to function.",
          "score": 0.7671834230422974
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c7",
          "thought1_idx": 8,
          "thought2_idx": 8,
          "text1": "Wait, the question says the mutation Y is in the dimerization domain and is dominant-negative. So when Y is present, even in a heterozygous state, the mutant protein interferes with the wild-type. So the wild-type allele is not expressed, or its function is blocked.\n\nIn this case, when the inactive transcription factor is phosphorylated, it should dimerize. But if Y is present, the dimerization can't happen properly, so the activated protein can't form dimers. So the dimerization is prevented, which means the transcription factor doesn't go into the nucleus, so gene transcription doesn't occur. So the function is lost.\n\nLooking at the options, which is about the molecular phenotype.\n\nOption D says protein aggregation and loss of function. So if the mutant Y subunits can't dimerize, perhaps they form aggregates or multimers that aren't functional. So the presence of Y leads to protein aggregation and the transcription factor can't function, leading to loss of function.",
          "text2": "Wait, but the question is about the molecular phenotype. So, in the presence of Y, what's happening?\n\nIf the transcription factor can't dimerize, then even if the rest of the process (phosphorylation, moving into nucleus) happens, the dimer is necessary for function. So without dimerization, the transcription factor can't function, leading to loss of function.\n\nBut looking at the options, the question is about the mutation Y's effect. So, Y is a dominant-negative in the dimerization domain. So, the presence of Y would prevent proper dimer formation, perhaps leading to the inability of the transcription factor to function.\n\nWhich option reflects this? Let's look again at the options.\n\nOption D says protein aggregation and loss of function. That would imply that the proteins are clumping together and not functioning, leading to a loss.\n\nOption B says protein degradation and loss of function of wild-type. I'm less sure about this. Degradation because of Y? Maybe the mutant Y is marked for degradation, but would that degrade the wild-type proteins too?",
          "score": 0.9459652900695801
        },
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c8",
          "thought1_idx": 8,
          "thought2_idx": 5,
          "text1": "Wait, but the question is about the presence of Y. The molecular phenotype is what happens to the proteins.\n\nIf Y is a dominant-negative, then the mutant and wild-type form non-functional dimers. So the proteins are present but not active.\n\nSo would that lead to protein degradation? Or would they just not function?\n\nIn most cases, if the protein can't fold properly, it might be targeted for degradation via the proteasome. But in the case of dominant-negative, the WT and mutant might form dimers that are not functional but are still present.",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.8568181395530701
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c5",
          "thought1_idx": 9,
          "thought2_idx": 9,
          "text1": "Alternatively, maybe the dimerization is prevented, but not necessarily aggregation. Then, the protein would remain as monomers, unable to dimerize. So without dimerization, the protein can't function. So the molecular phenotype would be loss of dimerization, leading to loss of function.",
          "text2": "Wait, none of the options directly mention dimerization. Let me check the options again.\n\nOption A: change of conformation and gain of function.\n\nOption B: protein degradation and loss of function.\n\nOption C: loss of dimerization and wild-type phenotype.\n\nOption D: protein aggregation and loss of function.\n\nHmm, none of the options directly say 'loss of dimerization and loss of function.' So perhaps the closest is D, where the protein can't form dimers, leading to aggregation.",
          "score": 0.7986297011375427
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c5",
          "thought1_idx": 10,
          "thought2_idx": 7,
          "text1": "Alternatively, perhaps when the mutant is present, the wild-type proteins can't form dimers, so they can't function, causing a loss of function. So the phenotype would be loss of function, but the proteins aren't necessarily degraded or aggregated.",
          "text2": "Wait, the options:\n\nOption D: protein aggregation and loss of function.\n\nOption B: protein degradation and loss of function.\n\nOption C: loss of dimerization and wild-type phenotype. No, the phenotype isn't wild-type.",
          "score": 0.8194751739501953
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c2",
          "thought1_idx": 10,
          "thought2_idx": 9,
          "text1": "Another angle: the wild-type allele's function being lost. If Y is dominant-negative, it inhibits the wild-type allele, making its protein unable to function. So the wild-type protein's function is lost because it's being interfered with by Y.\n\nBut if the wild-type is present but can't function due to Y, then the overall effect is loss of function, but is the protein being degraded or just non-functional?",
          "text2": "Wait, but option B is protein degradation and loss of wild-type function. That would happen if the mutant Y somehow caused the wild-type proteins to be targeted for degradation. But in dominant-negative scenarios, the proteins are usually not broken down but just non-functional.\n\nSo between options D and B. I think the key here is that the dominant-negative mutation Y would cause the wild-type proteins to be unable to function because they form non-functional dimers with Y. So the presence of Y would lead to the inability of the wild-type allele to function. However, the proteins themselves may not be degraded; they just can't form the right structures.",
          "score": 0.8717443943023682
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c4",
          "thought1_idx": 11,
          "thought2_idx": 10,
          "text1": "Wait, but the options don't have an option that just says loss of function. Let me check the options again.\n\nOptions:\n\nA) change of conformation and gain\n\nB) degradation and loss of wild-type\n\nC) loss of dimerization and wild-type (no, because if dimerization is lost, the phenotype should be loss)\n\nD) aggregation and loss.",
          "text2": "Wait, the options don't include \"loss of dimerization\" as a separate choice, but option C says \"loss of protein dimerization and wild-type phenotype\", which doesn't make sense because the function would be lost, not wild-type.\n\nHmm, perhaps I'm overcomplicating this. Let's think about what each option describes.\n\nOption D: protein aggregation and loss of function. So the protein can't dimerize properly, leading to aggregation (like inclusion bodies or something) and the function is lost.",
          "score": 0.764755368232727
        },
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c2",
          "thought1_idx": 11,
          "thought2_idx": 5,
          "text1": "Another angle: in a dominant-negative scenario, the mutant interferes with the function of the normal allele. So when the person is heterozygous (wild-type and Y), the Y allele's product (which is mutant) will interfere with the wild-type product's ability to function.\n\nSince Y is in the dimerization domain, when the two subunits try to come together, perhaps the mutant Y prevents proper dimerization. So the wild-type can't form functional dimers, leading to the inability to translocate to the nucleus and activate transcription.\n\nSo the result would be that the transcription factor doesn't function, leading to a loss of function. So the phenotype is loss of function.\n\nLooking at the options, options B, C, D have loss of function. So the question is about the molecular phenotype. What's happening to the proteins?\n\nOption D says protein aggregation and loss of function. So perhaps the proteins can't form the proper dimers and instead form aggregates.",
          "text2": "Wait, the question is about the molecular phenotype. So what's happening at the molecular level?\n\nDominant-negative mutations often lead to the formation of non-functional complexes. So the presence of Y would mean that the wild-type allele's product (the transcription factor) can't form functional dimers because they are associating with the mutant Y subunits which prevent proper dimerization.\n\nSo the wild-type proteins are present but can't function because they're stuck in non-functional dimers. The mutant Y doesn't form functional dimers on its own, but can interfere with the wild-type.\n\nSo the overall result is that the transcription factor can't function, leading to loss of gene transcription. So the phenotype would be loss-of-function.\n\nLooking at the options again:\n\nOption D says protein aggregation and loss-of-function. If the mutant prevents proper dimerization, perhaps the proteins don't aggregate but are just unable to form the correct structures.",
          "score": 0.9457690715789795
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c5",
          "thought1_idx": 12,
          "thought2_idx": 3,
          "text1": "Alternatively, perhaps the mutant Y doesn't allow proper dimerization, so the proteins can't form the correct structures, so they don't move to the nucleus, effectively making the transcription factor non-functional. So the phenotype is loss of function, but no degradation necessarily.",
          "text2": "Alternatively, without proper dimerization, maybe the proteins can't function, leading to their inability to enter the nucleus. So the result is that the gene transcription doesn't happen, leading to a loss of function.\n\nThe options:\n\nA) Gain of function: no, it's a dominant-negative, so it's loss of function.\n\nB) Protein degradation: perhaps, but the question doesn't mention anything about degradation. It's more about dimerization. So maybe not.\n\nC) Wild-type phenotype: No, the presence of Y would cause a loss of function. It says in the presence of Y, which is dominant-negative, so the phenotype would be loss of function.\n\nOption D: protein aggregation and loss of function. If the mutant Y causes the proteins to aggregate, perhaps they form insoluble clumps, which would prevent their proper function. So the proteins can't dimerize correctly and form aggregates, leading to loss of function.",
          "score": 0.8321651220321655
        },
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c1",
          "thought1_idx": 12,
          "thought2_idx": 8,
          "text1": "Alternatively, if they can't form dimers, maybe they don't aggregate but are just not functional.\n\nOption B says protein degradation. Maybe the mutant Y is subject to degradation, but the wild-type would still be present. But since the Y is dominant-negative, perhaps both alleles are affected.",
          "text2": "Alternatively, they might form non-functional dimers.\n\nLooking at the options again, which one says \"loss of function\" and some other effect.\n\nOption B: protein degradation and loss. If the mutation Y causes the proteins to be degraded, then both the mutant and wild-type might be degraded. But the scenario says it's a dominant-negative, so perhaps the mutant doesn't get degraded but prevents the wild-type from working.",
          "score": 0.8202989101409912
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c1",
          "thought1_idx": 15,
          "thought2_idx": 4,
          "text1": "Alternatively, if the dimerization is critical for nuclear import, and the mutant Y prevents this, the proteins might remain in the cytoplasm and not enter the nucleus, leading to loss of function. But this doesn't necessarily cause protein aggregation.\n\nSo perhaps the molecular phenotype is that the proteins can't dimerize, so they're stuck as monomers and can't function. So the presence of Y would lead to loss of dimerization, thus loss of function.\n\nLooking back at the options, option D involves protein aggregation, which I'm not sure about. Option B is about degradation. Option C says loss of dimerization and wild-type phenotype, which doesn't make sense because the phenotype would be loss.",
          "text2": "Alternatively, when the mutant Y is present, the normal protein can't form dimers, so they might not be able to enter the nucleus. So the transcription factor doesn't work, leading to loss of function.\n\nSo which option aligns with this?\n\nOption D says protein aggregation and loss-of-function. But does the mutant cause aggregation? Or does it just prevent dimerization?",
          "score": 0.9081236124038696
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c4",
          "thought1_idx": 16,
          "thought2_idx": 8,
          "text1": "Wait, the missense mutation Y is in the dimerization domain. So the mutant's dimerization domain is faulty. When a wild-type subunit and a Y subunit try to dimerize, they can't form a functional dimer. So the dimerization can't occur, so the protein doesn't enter the nucleus, and gene transcription doesn't happen.\n\nSo the molecular change would be the inability to dimerize. Therefore, the answer should involve loss of dimerization. Looking at the options, only option C mentions loss of dimerization, but its second part is incorrect.",
          "text2": "Wait, the question says the mutation Y is in the dimerization domain and is dominant-negative. So when Y is present, even in a heterozygous state, the mutant protein interferes with the wild-type. So the wild-type allele is not expressed, or its function is blocked.\n\nIn this case, when the inactive transcription factor is phosphorylated, it should dimerize. But if Y is present, the dimerization can't happen properly, so the activated protein can't form dimers. So the dimerization is prevented, which means the transcription factor doesn't go into the nucleus, so gene transcription doesn't occur. So the function is lost.\n\nLooking at the options, which is about the molecular phenotype.\n\nOption D says protein aggregation and loss of function. So if the mutant Y subunits can't dimerize, perhaps they form aggregates or multimers that aren't functional. So the presence of Y leads to protein aggregation and the transcription factor can't function, leading to loss of function.",
          "score": 0.8433146476745605
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c1",
          "thought1_idx": 16,
          "thought2_idx": 12,
          "text1": "Wait, but the question is about the presence of mutation Y. The key is that Y is dominant-negative, so the heterozygous state leads to the mutant allele preventing the wild-type from functioning.\n\nSo, in terms of the effect on the protein:\n\n- The mutant Y can't dimerize, so when it's present, it can't form the necessary dimers, thus the transcription factor can't function. So the phenotype is loss of function.\n\nLooking back at the options, D says protein aggregation and loss of function. This would fit if the mutant proteins aggregate, but I'm not certain.",
          "text2": "Wait, option C says loss of dimerization and wild-type phenotype. That doesn't make sense. If dimerization is lost, the phenotype can't be wild-type. So that's not correct.\n\nSo, back to the options.\n\nThe Y mutation is in the dimerization domain and is dominant-negative. So the mutant subunits would interfere with the wild-type's ability to dimerize.\n\nIn a heterozygous state, there are some wild-type and some mutant proteins.\n\nWhen the mutant proteins are present, they might form non-functional dimers with the wild-type, or perhaps prevent the wild-type from finding a partner to dimerize with.\n\nSo, the wild-type protein's ability to dimerize is blocked, so the transcription factor can't function. Thus, the phenotype is a loss of function.\n\nLooking at the options, which have a loss of function.\n\nOption B: protein degradation and loss of wild-type function.\n\nOption D: protein aggregation and loss.\n\nBut I think in dominant-negative, the proteins are present but non-functional. So no degradation, but they can't form functional dimers.\n\nSo perhaps the molecular phenotype is that the proteins can't dimerize, leading to loss of function.\n\nSo, looking for an option that says loss of dimerization and loss of function. But none of the options directly state that.",
          "score": 0.939691424369812
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c8",
          "thought1_idx": 17,
          "thought2_idx": 5,
          "text1": "Wait, but because it's a dominant-negative, the presence of Y in the cell would affect the function of the wild-type. If the Y subunits can still bind to wild-type subunits, then the resulting dimers would be non-functional. So the wild-type subunits are present but can't form functional dimers because they're stuck with the mutant Y.\n\nSo the result is that the transcription factor can't function, leading to loss of function.\n\nSo the molecular phenotype would involve the inability to dimerize, leading to loss of function. But looking at the options, none of them directly say that. The options are about the proteins\u2014either their conformation, aggregation, degradation, etc.\n\nIn the presence of Y, the proteins can't form dimers, so they don't perform their function. But what about their presence in the cell? Do they aggregate?",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.9297323226928711
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c8",
          "thought1_idx": 19,
          "thought2_idx": 2,
          "text1": "Alternatively, the mutant Y could cause the entire complex to be non-functional, leading to the protein not being active, but perhaps the proteins are still present.\n\nSo, the dominant-negative effect would mean that the presence of Y prevents the normal function of the transcription factor. So the outcome is that the transcription factor can't function, leading to loss of function.\n\nWhich options have loss of function? A is gain, so no. B and D are loss. C is wild-type.\n\nSo between B and D.\n\nOption B: protein degradation and loss of wild-type. So, the mutant Y's protein is being degraded, perhaps due to misfolding. But would that affect the wild-type? Maybe not directly. But if the mutant Y is causing the wild-type proteins to be unable to form dimers, perhaps the wild-type proteins are stuck in the cytoplasm and get degraded.",
          "text2": "Wait, but what's the effect of dominant-negative in this case? The mutant Y would interfere with the dimerization of the wild-type. So the presence of Y would mean that even the wild-type subunits can't form active dimers because they pair with the mutant Y, which can't form proper dimers. So the result is that the transcription factor doesn't function, leading to a loss of function.\n\nLooking back at the options, in D, the proteins aggregate and function is lost.",
          "score": 0.916894257068634
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c3",
          "thought1_idx": 22,
          "thought2_idx": 3,
          "text1": "Wait, another angle: when a protein is dominant-negative, it often means that it interferes with the normal function of the wild-type protein. So, in this case, the Y mutant might form non-functional dimers with the wild-type, preventing them from functioning. So the overall effect is that the transcription factor can't function, leading to loss of function.\n\nBut the question is about the molecular phenotype. So, what's happening at the molecular level?\n\nOption D says protein aggregation and loss of function.",
          "text2": "Wait, but how does dominant-negative work? The mutant subunits might form nonfunctional dimers with wild-type subunits. So when Y is present, any wild-type subunits would pair with Y, making a dimer that can't function. So the transactivation doesn't happen, no gene expression.\n\nSo the effect is that the transcription factor can't function because the dimerization is impaired, leading to loss of function. \n\nLooking back at the options, which one fits this? Let's see:\n\nOption D says protein aggregation and loss. If Y causes the proteins to aggregate, then they're not functional, so the phenotype is loss.\n\nOption B says protein degradation. I'm not sure if Y would lead to degradation. It could, but I think dominant-negative often doesn't destroy the protein but stops it from working, perhaps by causing misfolding or improper interactions.",
          "score": 0.9446625113487244
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c8",
          "thought1_idx": 26,
          "thought2_idx": 5,
          "text1": "Alternatively, perhaps the dominant-negative Y causes the mutant protein to aggregate, leading to the loss of function. So the molecular change is aggregation, and the phenotype is loss of function. That would make option D correct.\n\nBut I'm not sure if aggregation is the correct molecular change. Maybe the presence of Y doesn't cause the proteins to aggregate but just prevents dimerization.",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.8950203061103821
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c6",
          "thought1_idx": 30,
          "thought2_idx": 5,
          "text1": "Alternatively, perhaps the answer is D. Because when a dominant-negative mutation is present, the mutant proteins can interfere with the wild-type, perhaps leading to the formation of aggregates (misfolded proteins) which can't function, thus leading to loss of function.\n\nSo in that case, the molecular phenotype would involve aggregation, making option D correct.",
          "text2": "Another approach: dominant-negative in the dimerization domain. When a dominant-negative mutation is present, the mutant protein can't function on its own, but can disrupt the function of the wild-type protein.\n\nSo for example, suppose the protein normally forms homo-dimers. If one subunit is mutant Y, it can't form a proper dimer. If the mutant Y binds to the wild-type, it might form a hetero-dimer that doesn't function. So the presence of Y would mean that even when the wild-type is present, the overall activity is reduced because many of the dimers are non-functional.\n\nIn this case, dimerization is affected, leading to a loss of function. So the molecular phenotype would be that the proteins can't dimerize (so loss of dimerization) and the phenotype is loss of function.\n\nLooking at the options again:\n\nOption D: protein aggregation and loss of function. So if the proteins can't dimerize, they might form aggregates? Or perhaps the mutant is not properly folded and aggregates.",
          "score": 0.8662033081054688
        }
      ],
      "num_detected": 24,
      "num_same_answer": 24,
      "same_answer_perc": 100.0
    },
    "0.8": {
      "detected_pairs": [
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c7",
          "thought1_idx": 2,
          "thought2_idx": 2,
          "text1": "Alternatively, maybe the wild-type and mutant can't form a proper dimer, so they're not functional. So the cell's transcription factor activity goes down, leading to a loss-of-function phenotype.\n\nOption B says protein degradation. I'm not sure if Y causes the proteins to degrade. If the mutant Y is not properly processed, maybe it gets degraded, but the wild-type might be as well if it's bound. Or perhaps the mutant doesn't interfere with degradation.",
          "text2": "Wait, why would the wild-type allele be degraded? I'm not sure. The mutation Y is dominant-negative, so it affects the wild-type's ability to function, but I don't think it causes the protein to degrade. Unless the mutant proteins aggregate and cause the cell to degrade them.\n\nOption C: Loss of dimerization and wild-type phenotype. No, because if dimerization is lost, the transcription factor can't function, so the phenotype would be a loss of function, not wild-type.\n\nOption D: Protein aggregation and loss-of-function. Aggregation might happen if the mutant proteins form faulty structures, leading to the formation of aggregates. If the proteins can't dimerize correctly, they might clump together, and the cell might degrade them. That would prevent the transcription factor from working, leading to a loss of function.",
          "score": 0.9003003835678101
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c5",
          "thought1_idx": 3,
          "thought2_idx": 2,
          "text1": "Wait, but the question is about the presence of mutation Y. So in a heterozygous state, you have some wild-type and some Y mutant proteins. The Y mutant can't form dimers, and when they try to interact with wild-type, maybe the whole complex isn't functional. So the transcription factor doesn't dimerize, doesn't go into the nucleus, and doesn't activate genes. So the phenotype is loss of function.\n\nLooking again at the options, D says protein aggregation and loss.",
          "text2": "Wait, going back. Let's think about dominant-negative mutations. In this case, the mutant Y would form a non-functional dimer when paired with wild-type. Because the dimerization domain is messed up, they can't form active dimers. So the Y mutant prevents the wild-type from functioning. So in a heterozygote, the wild-type allele is expressed but can't form active dimers because it's either binding to the mutant Y or the mutant Y is preventing the proper folding.\n\nSo the presence of Y leads to the inability of the transcription factor to dimerize, which means it can't enter the nucleus and activate gene transcription. So the phenotype would be a loss-of-function.\n\nLooking at the options, I think D says protein aggregation and loss of function. Or B says protein degradation. But I'm not sure.",
          "score": 0.9209001064300537
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c3",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Alternatively, perhaps the presence of Y causes the mutant protein to form non-functional dimers, leading to loss of function. So the dominant-negative effect is causing the loss. So looking at the options, which one matches this scenario.\n\nOption D: Aggregation and loss. I'm not sure about the aggregation part.",
          "text2": "Wait, but how does dominant-negative work? The mutant subunits might form nonfunctional dimers with wild-type subunits. So when Y is present, any wild-type subunits would pair with Y, making a dimer that can't function. So the transactivation doesn't happen, no gene expression.\n\nSo the effect is that the transcription factor can't function because the dimerization is impaired, leading to loss of function. \n\nLooking back at the options, which one fits this? Let's see:\n\nOption D says protein aggregation and loss. If Y causes the proteins to aggregate, then they're not functional, so the phenotype is loss.\n\nOption B says protein degradation. I'm not sure if Y would lead to degradation. It could, but I think dominant-negative often doesn't destroy the protein but stops it from working, perhaps by causing misfolding or improper interactions.",
          "score": 0.8802888989448547
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c6",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Wait, what's the molecular phenotype? The question says which molecular phenotype is observed. So options are about what molecular changes occur.\n\nOption D says protein aggregation and loss of function. So if the mutant Y leads to the protein aggregating, and thus not functioning, that would fit.",
          "text2": "Alternatively, perhaps the presence of Y leads to the inability of the wild-type to function. So the cells can't transcribe the gene, leading to loss of function. So the phenotype would be loss-of-function.\n\nLooking again at the options:\n\nOption B: protein degradation and loss of wild-type allele function. Not sure if degradation is a factor here.\n\nOption D: protein aggregation and loss of function. Aggregation might happen if the mutant and wild-type can't form correct dimers, so they aggregate, leading to no functional protein.\n\nSo the molecular phenotype would be that the proteins can't form dimers (so no dimerization) and the overall function is lost. So which option matches that.\n\nOption D says protein aggregation and loss of function. That makes sense. Or, if it's about dimerization, maybe option C is about loss of dimerization, but the phenotype would be loss of function, so option C is 'wild-type phenotype' which doesn't fit.",
          "score": 0.875187873840332
        },
        {
          "chain1_id": "q158_c8",
          "chain2_id": "q158_c1",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "text2": "Wait, the question is about the molecular phenotype when Y is present. So in the cell, the mutant Y protein is present. Since it\u2019s dominant-negative, when the mutant and wild-type proteins try to dimerize, they form non-functional dimers because Y is in the dimerization domain.\n\nSo the mutant Y would prevent the wild-type from dimerizing correctly. So the result is that the transcription factor can't function because the dimerization doesn't happen. So the phenotype is loss-of-function.\n\nLooking back at the options, which match this.\n\nOption D says protein aggregation and loss-of-function. I'm not sure if the proteins aggregate, but in dominant-negative situations, the mutant might interfere with the wild-type, leading to non-functional dimers. So more likely, the phenotype is loss-of-function.\n\nLooking at the options again:\n\nOption B: Protein degradation and loss of wild-type. I'm not sure about degradation. Option D says aggregation and loss.",
          "score": 0.9468410015106201
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c7",
          "thought1_idx": 8,
          "thought2_idx": 8,
          "text1": "Wait, the question says the mutation Y is in the dimerization domain and is dominant-negative. So when Y is present, even in a heterozygous state, the mutant protein interferes with the wild-type. So the wild-type allele is not expressed, or its function is blocked.\n\nIn this case, when the inactive transcription factor is phosphorylated, it should dimerize. But if Y is present, the dimerization can't happen properly, so the activated protein can't form dimers. So the dimerization is prevented, which means the transcription factor doesn't go into the nucleus, so gene transcription doesn't occur. So the function is lost.\n\nLooking at the options, which is about the molecular phenotype.\n\nOption D says protein aggregation and loss of function. So if the mutant Y subunits can't dimerize, perhaps they form aggregates or multimers that aren't functional. So the presence of Y leads to protein aggregation and the transcription factor can't function, leading to loss of function.",
          "text2": "Wait, but the question is about the molecular phenotype. So, in the presence of Y, what's happening?\n\nIf the transcription factor can't dimerize, then even if the rest of the process (phosphorylation, moving into nucleus) happens, the dimer is necessary for function. So without dimerization, the transcription factor can't function, leading to loss of function.\n\nBut looking at the options, the question is about the mutation Y's effect. So, Y is a dominant-negative in the dimerization domain. So, the presence of Y would prevent proper dimer formation, perhaps leading to the inability of the transcription factor to function.\n\nWhich option reflects this? Let's look again at the options.\n\nOption D says protein aggregation and loss of function. That would imply that the proteins are clumping together and not functioning, leading to a loss.\n\nOption B says protein degradation and loss of function of wild-type. I'm less sure about this. Degradation because of Y? Maybe the mutant Y is marked for degradation, but would that degrade the wild-type proteins too?",
          "score": 0.9459652900695801
        },
        {
          "chain1_id": "q158_c5",
          "chain2_id": "q158_c3",
          "thought1_idx": 8,
          "thought2_idx": 8,
          "text1": "Alternatively, the presence of Y in the dimerization domain may prevent the protein from forming dimers. So, even if a wild-type allele is present, the mutant Y would cause the proteins not to form dimers, leading to a loss of function. So the molecular phenotype would be the inability to dimerize, leading to loss of function.\n\nLooking at the options, which option says loss of dimerization and loss of function.",
          "text2": "Alternatively, the mutation Y is causing the mutant protein to interfere in dimerization, so dimerization doesn't occur. So the molecular phenotype is loss of dimerization, which would lead to loss of function.\n\nBut the options don't have an option that directly states loss of dimerization. Let me check the options again.\n\nOptions:\n\nA) Change of protein conformation and gain-of-function.\n\nB) Protein degradation and loss-of-function of the wild-type allele.\n\nC) Loss of protein dimerization and wild-type phenotype.\n\nD) Protein aggregation and loss-of-function phenotype.\n\nHmm. From what I understand, the presence of Y (dominant-negative) would lead to the inability to form functional dimers. So the molecular change is loss of dimerization, which is option C's first part. But option C's second part says wild-type phenotype, which doesn't make sense. Because if dimerization doesn't happen, the transcription factor can't function, so the phenotype is loss of function, not wild-type.",
          "score": 0.8863629102706909
        },
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c8",
          "thought1_idx": 8,
          "thought2_idx": 5,
          "text1": "Wait, but the question is about the presence of Y. The molecular phenotype is what happens to the proteins.\n\nIf Y is a dominant-negative, then the mutant and wild-type form non-functional dimers. So the proteins are present but not active.\n\nSo would that lead to protein degradation? Or would they just not function?\n\nIn most cases, if the protein can't fold properly, it might be targeted for degradation via the proteasome. But in the case of dominant-negative, the WT and mutant might form dimers that are not functional but are still present.",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.8568181395530701
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c5",
          "thought1_idx": 10,
          "thought2_idx": 7,
          "text1": "Alternatively, perhaps when the mutant is present, the wild-type proteins can't form dimers, so they can't function, causing a loss of function. So the phenotype would be loss of function, but the proteins aren't necessarily degraded or aggregated.",
          "text2": "Wait, the options:\n\nOption D: protein aggregation and loss of function.\n\nOption B: protein degradation and loss of function.\n\nOption C: loss of dimerization and wild-type phenotype. No, the phenotype isn't wild-type.",
          "score": 0.8194751739501953
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c4",
          "thought1_idx": 10,
          "thought2_idx": 6,
          "text1": "Wait, but if the dimerization doesn't happen, the proteins might not be able to move into the nucleus. So they stay in the cytoplasm. That's a possibility.\n\nLooking at the options, option D says protein aggregation and loss-of-function. Would dimerization issues lead to aggregation? I'm not entirely sure.",
          "text2": "Alternatively, if the dimerization doesn't occur, the proteins stay in the cytoplasm, maybe as monomers, but without entering the nucleus.",
          "score": 0.8326417803764343
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c5",
          "thought1_idx": 10,
          "thought2_idx": 9,
          "text1": "Wait, the options don't include \"loss of dimerization\" as a separate choice, but option C says \"loss of protein dimerization and wild-type phenotype\", which doesn't make sense because the function would be lost, not wild-type.\n\nHmm, perhaps I'm overcomplicating this. Let's think about what each option describes.\n\nOption D: protein aggregation and loss of function. So the protein can't dimerize properly, leading to aggregation (like inclusion bodies or something) and the function is lost.",
          "text2": "Wait, none of the options directly mention dimerization. Let me check the options again.\n\nOption A: change of conformation and gain of function.\n\nOption B: protein degradation and loss of function.\n\nOption C: loss of dimerization and wild-type phenotype.\n\nOption D: protein aggregation and loss of function.\n\nHmm, none of the options directly say 'loss of dimerization and loss of function.' So perhaps the closest is D, where the protein can't form dimers, leading to aggregation.",
          "score": 0.8725942373275757
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c2",
          "thought1_idx": 10,
          "thought2_idx": 9,
          "text1": "Another angle: the wild-type allele's function being lost. If Y is dominant-negative, it inhibits the wild-type allele, making its protein unable to function. So the wild-type protein's function is lost because it's being interfered with by Y.\n\nBut if the wild-type is present but can't function due to Y, then the overall effect is loss of function, but is the protein being degraded or just non-functional?",
          "text2": "Wait, but option B is protein degradation and loss of wild-type function. That would happen if the mutant Y somehow caused the wild-type proteins to be targeted for degradation. But in dominant-negative scenarios, the proteins are usually not broken down but just non-functional.\n\nSo between options D and B. I think the key here is that the dominant-negative mutation Y would cause the wild-type proteins to be unable to function because they form non-functional dimers with Y. So the presence of Y would lead to the inability of the wild-type allele to function. However, the proteins themselves may not be degraded; they just can't form the right structures.",
          "score": 0.8717443943023682
        },
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c2",
          "thought1_idx": 11,
          "thought2_idx": 5,
          "text1": "Another angle: in a dominant-negative scenario, the mutant interferes with the function of the normal allele. So when the person is heterozygous (wild-type and Y), the Y allele's product (which is mutant) will interfere with the wild-type product's ability to function.\n\nSince Y is in the dimerization domain, when the two subunits try to come together, perhaps the mutant Y prevents proper dimerization. So the wild-type can't form functional dimers, leading to the inability to translocate to the nucleus and activate transcription.\n\nSo the result would be that the transcription factor doesn't function, leading to a loss of function. So the phenotype is loss of function.\n\nLooking at the options, options B, C, D have loss of function. So the question is about the molecular phenotype. What's happening to the proteins?\n\nOption D says protein aggregation and loss of function. So perhaps the proteins can't form the proper dimers and instead form aggregates.",
          "text2": "Wait, the question is about the molecular phenotype. So what's happening at the molecular level?\n\nDominant-negative mutations often lead to the formation of non-functional complexes. So the presence of Y would mean that the wild-type allele's product (the transcription factor) can't form functional dimers because they are associating with the mutant Y subunits which prevent proper dimerization.\n\nSo the wild-type proteins are present but can't function because they're stuck in non-functional dimers. The mutant Y doesn't form functional dimers on its own, but can interfere with the wild-type.\n\nSo the overall result is that the transcription factor can't function, leading to loss of gene transcription. So the phenotype would be loss-of-function.\n\nLooking at the options again:\n\nOption D says protein aggregation and loss-of-function. If the mutant prevents proper dimerization, perhaps the proteins don't aggregate but are just unable to form the correct structures.",
          "score": 0.9457690715789795
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c5",
          "thought1_idx": 12,
          "thought2_idx": 3,
          "text1": "Alternatively, perhaps the mutant Y doesn't allow proper dimerization, so the proteins can't form the correct structures, so they don't move to the nucleus, effectively making the transcription factor non-functional. So the phenotype is loss of function, but no degradation necessarily.",
          "text2": "Alternatively, without proper dimerization, maybe the proteins can't function, leading to their inability to enter the nucleus. So the result is that the gene transcription doesn't happen, leading to a loss of function.\n\nThe options:\n\nA) Gain of function: no, it's a dominant-negative, so it's loss of function.\n\nB) Protein degradation: perhaps, but the question doesn't mention anything about degradation. It's more about dimerization. So maybe not.\n\nC) Wild-type phenotype: No, the presence of Y would cause a loss of function. It says in the presence of Y, which is dominant-negative, so the phenotype would be loss of function.\n\nOption D: protein aggregation and loss of function. If the mutant Y causes the proteins to aggregate, perhaps they form insoluble clumps, which would prevent their proper function. So the proteins can't dimerize correctly and form aggregates, leading to loss of function.",
          "score": 0.8321651220321655
        },
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c1",
          "thought1_idx": 12,
          "thought2_idx": 8,
          "text1": "Alternatively, if they can't form dimers, maybe they don't aggregate but are just not functional.\n\nOption B says protein degradation. Maybe the mutant Y is subject to degradation, but the wild-type would still be present. But since the Y is dominant-negative, perhaps both alleles are affected.",
          "text2": "Alternatively, they might form non-functional dimers.\n\nLooking at the options again, which one says \"loss of function\" and some other effect.\n\nOption B: protein degradation and loss. If the mutation Y causes the proteins to be degraded, then both the mutant and wild-type might be degraded. But the scenario says it's a dominant-negative, so perhaps the mutant doesn't get degraded but prevents the wild-type from working.",
          "score": 0.8202989101409912
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c4",
          "thought1_idx": 13,
          "thought2_idx": 2,
          "text1": "Wait, option C says loss of dimerization and wild-type. That's contradictory. So it's not that.\n\nOption D: aggregation and loss. Maybe the mutant Y causes the proteins to aggregate, which would prevent them from functioning.",
          "text2": "Wait, if the proteins can't dimerize, the function is lost, so the phenotype would be loss-of-function, not wild-type. So C's description seems conflicting. It says the phenotype is wild-type, but if dimerization doesn't happen, the function is lost. So C is probably incorrect.\n\nOption D: Protein aggregation and loss-of-function. Well, if the mutant Y can't dimerize correctly, maybe it forms aggregates. Like, misfolded proteins sometimes aggregate. So the presence of Y could lead to aggregation (misfolded proteins sticking together), and since the dimerization doesn't happen, the function is lost. So D seems possible.",
          "score": 0.9136219024658203
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c1",
          "thought1_idx": 15,
          "thought2_idx": 4,
          "text1": "Alternatively, if the dimerization is critical for nuclear import, and the mutant Y prevents this, the proteins might remain in the cytoplasm and not enter the nucleus, leading to loss of function. But this doesn't necessarily cause protein aggregation.\n\nSo perhaps the molecular phenotype is that the proteins can't dimerize, so they're stuck as monomers and can't function. So the presence of Y would lead to loss of dimerization, thus loss of function.\n\nLooking back at the options, option D involves protein aggregation, which I'm not sure about. Option B is about degradation. Option C says loss of dimerization and wild-type phenotype, which doesn't make sense because the phenotype would be loss.",
          "text2": "Alternatively, when the mutant Y is present, the normal protein can't form dimers, so they might not be able to enter the nucleus. So the transcription factor doesn't work, leading to loss of function.\n\nSo which option aligns with this?\n\nOption D says protein aggregation and loss-of-function. But does the mutant cause aggregation? Or does it just prevent dimerization?",
          "score": 0.9081236124038696
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c4",
          "thought1_idx": 16,
          "thought2_idx": 8,
          "text1": "Wait, the missense mutation Y is in the dimerization domain. So the mutant's dimerization domain is faulty. When a wild-type subunit and a Y subunit try to dimerize, they can't form a functional dimer. So the dimerization can't occur, so the protein doesn't enter the nucleus, and gene transcription doesn't happen.\n\nSo the molecular change would be the inability to dimerize. Therefore, the answer should involve loss of dimerization. Looking at the options, only option C mentions loss of dimerization, but its second part is incorrect.",
          "text2": "Wait, the question says the mutation Y is in the dimerization domain and is dominant-negative. So when Y is present, even in a heterozygous state, the mutant protein interferes with the wild-type. So the wild-type allele is not expressed, or its function is blocked.\n\nIn this case, when the inactive transcription factor is phosphorylated, it should dimerize. But if Y is present, the dimerization can't happen properly, so the activated protein can't form dimers. So the dimerization is prevented, which means the transcription factor doesn't go into the nucleus, so gene transcription doesn't occur. So the function is lost.\n\nLooking at the options, which is about the molecular phenotype.\n\nOption D says protein aggregation and loss of function. So if the mutant Y subunits can't dimerize, perhaps they form aggregates or multimers that aren't functional. So the presence of Y leads to protein aggregation and the transcription factor can't function, leading to loss of function.",
          "score": 0.8433146476745605
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c1",
          "thought1_idx": 16,
          "thought2_idx": 12,
          "text1": "Wait, but the question is about the presence of mutation Y. The key is that Y is dominant-negative, so the heterozygous state leads to the mutant allele preventing the wild-type from functioning.\n\nSo, in terms of the effect on the protein:\n\n- The mutant Y can't dimerize, so when it's present, it can't form the necessary dimers, thus the transcription factor can't function. So the phenotype is loss of function.\n\nLooking back at the options, D says protein aggregation and loss of function. This would fit if the mutant proteins aggregate, but I'm not certain.",
          "text2": "Wait, option C says loss of dimerization and wild-type phenotype. That doesn't make sense. If dimerization is lost, the phenotype can't be wild-type. So that's not correct.\n\nSo, back to the options.\n\nThe Y mutation is in the dimerization domain and is dominant-negative. So the mutant subunits would interfere with the wild-type's ability to dimerize.\n\nIn a heterozygous state, there are some wild-type and some mutant proteins.\n\nWhen the mutant proteins are present, they might form non-functional dimers with the wild-type, or perhaps prevent the wild-type from finding a partner to dimerize with.\n\nSo, the wild-type protein's ability to dimerize is blocked, so the transcription factor can't function. Thus, the phenotype is a loss of function.\n\nLooking at the options, which have a loss of function.\n\nOption B: protein degradation and loss of wild-type function.\n\nOption D: protein aggregation and loss.\n\nBut I think in dominant-negative, the proteins are present but non-functional. So no degradation, but they can't form functional dimers.\n\nSo perhaps the molecular phenotype is that the proteins can't dimerize, leading to loss of function.\n\nSo, looking for an option that says loss of dimerization and loss of function. But none of the options directly state that.",
          "score": 0.939691424369812
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c8",
          "thought1_idx": 17,
          "thought2_idx": 5,
          "text1": "Wait, but because it's a dominant-negative, the presence of Y in the cell would affect the function of the wild-type. If the Y subunits can still bind to wild-type subunits, then the resulting dimers would be non-functional. So the wild-type subunits are present but can't form functional dimers because they're stuck with the mutant Y.\n\nSo the result is that the transcription factor can't function, leading to loss of function.\n\nSo the molecular phenotype would involve the inability to dimerize, leading to loss of function. But looking at the options, none of them directly say that. The options are about the proteins\u2014either their conformation, aggregation, degradation, etc.\n\nIn the presence of Y, the proteins can't form dimers, so they don't perform their function. But what about their presence in the cell? Do they aggregate?",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.9297323226928711
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c8",
          "thought1_idx": 19,
          "thought2_idx": 2,
          "text1": "Alternatively, the mutant Y could cause the entire complex to be non-functional, leading to the protein not being active, but perhaps the proteins are still present.\n\nSo, the dominant-negative effect would mean that the presence of Y prevents the normal function of the transcription factor. So the outcome is that the transcription factor can't function, leading to loss of function.\n\nWhich options have loss of function? A is gain, so no. B and D are loss. C is wild-type.\n\nSo between B and D.\n\nOption B: protein degradation and loss of wild-type. So, the mutant Y's protein is being degraded, perhaps due to misfolding. But would that affect the wild-type? Maybe not directly. But if the mutant Y is causing the wild-type proteins to be unable to form dimers, perhaps the wild-type proteins are stuck in the cytoplasm and get degraded.",
          "text2": "Wait, but what's the effect of dominant-negative in this case? The mutant Y would interfere with the dimerization of the wild-type. So the presence of Y would mean that even the wild-type subunits can't form active dimers because they pair with the mutant Y, which can't form proper dimers. So the result is that the transcription factor doesn't function, leading to a loss of function.\n\nLooking back at the options, in D, the proteins aggregate and function is lost.",
          "score": 0.916894257068634
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c3",
          "thought1_idx": 22,
          "thought2_idx": 3,
          "text1": "Wait, another angle: when a protein is dominant-negative, it often means that it interferes with the normal function of the wild-type protein. So, in this case, the Y mutant might form non-functional dimers with the wild-type, preventing them from functioning. So the overall effect is that the transcription factor can't function, leading to loss of function.\n\nBut the question is about the molecular phenotype. So, what's happening at the molecular level?\n\nOption D says protein aggregation and loss of function.",
          "text2": "Wait, but how does dominant-negative work? The mutant subunits might form nonfunctional dimers with wild-type subunits. So when Y is present, any wild-type subunits would pair with Y, making a dimer that can't function. So the transactivation doesn't happen, no gene expression.\n\nSo the effect is that the transcription factor can't function because the dimerization is impaired, leading to loss of function. \n\nLooking back at the options, which one fits this? Let's see:\n\nOption D says protein aggregation and loss. If Y causes the proteins to aggregate, then they're not functional, so the phenotype is loss.\n\nOption B says protein degradation. I'm not sure if Y would lead to degradation. It could, but I think dominant-negative often doesn't destroy the protein but stops it from working, perhaps by causing misfolding or improper interactions.",
          "score": 0.9446625113487244
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c8",
          "thought1_idx": 26,
          "thought2_idx": 5,
          "text1": "Alternatively, perhaps the dominant-negative Y causes the mutant protein to aggregate, leading to the loss of function. So the molecular change is aggregation, and the phenotype is loss of function. That would make option D correct.\n\nBut I'm not sure if aggregation is the correct molecular change. Maybe the presence of Y doesn't cause the proteins to aggregate but just prevents dimerization.",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.8950203061103821
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c6",
          "thought1_idx": 30,
          "thought2_idx": 5,
          "text1": "Alternatively, perhaps the answer is D. Because when a dominant-negative mutation is present, the mutant proteins can interfere with the wild-type, perhaps leading to the formation of aggregates (misfolded proteins) which can't function, thus leading to loss of function.\n\nSo in that case, the molecular phenotype would involve aggregation, making option D correct.",
          "text2": "Another approach: dominant-negative in the dimerization domain. When a dominant-negative mutation is present, the mutant protein can't function on its own, but can disrupt the function of the wild-type protein.\n\nSo for example, suppose the protein normally forms homo-dimers. If one subunit is mutant Y, it can't form a proper dimer. If the mutant Y binds to the wild-type, it might form a hetero-dimer that doesn't function. So the presence of Y would mean that even when the wild-type is present, the overall activity is reduced because many of the dimers are non-functional.\n\nIn this case, dimerization is affected, leading to a loss of function. So the molecular phenotype would be that the proteins can't dimerize (so loss of dimerization) and the phenotype is loss of function.\n\nLooking at the options again:\n\nOption D: protein aggregation and loss of function. So if the proteins can't dimerize, they might form aggregates? Or perhaps the mutant is not properly folded and aggregates.",
          "score": 0.8662033081054688
        }
      ],
      "num_detected": 24,
      "num_same_answer": 24,
      "same_answer_perc": 100.0
    },
    "0.85": {
      "detected_pairs": [
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c7",
          "thought1_idx": 2,
          "thought2_idx": 2,
          "text1": "Alternatively, maybe the wild-type and mutant can't form a proper dimer, so they're not functional. So the cell's transcription factor activity goes down, leading to a loss-of-function phenotype.\n\nOption B says protein degradation. I'm not sure if Y causes the proteins to degrade. If the mutant Y is not properly processed, maybe it gets degraded, but the wild-type might be as well if it's bound. Or perhaps the mutant doesn't interfere with degradation.",
          "text2": "Wait, why would the wild-type allele be degraded? I'm not sure. The mutation Y is dominant-negative, so it affects the wild-type's ability to function, but I don't think it causes the protein to degrade. Unless the mutant proteins aggregate and cause the cell to degrade them.\n\nOption C: Loss of dimerization and wild-type phenotype. No, because if dimerization is lost, the transcription factor can't function, so the phenotype would be a loss of function, not wild-type.\n\nOption D: Protein aggregation and loss-of-function. Aggregation might happen if the mutant proteins form faulty structures, leading to the formation of aggregates. If the proteins can't dimerize correctly, they might clump together, and the cell might degrade them. That would prevent the transcription factor from working, leading to a loss of function.",
          "score": 0.9003003835678101
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c5",
          "thought1_idx": 3,
          "thought2_idx": 2,
          "text1": "Wait, but the question is about the presence of mutation Y. So in a heterozygous state, you have some wild-type and some Y mutant proteins. The Y mutant can't form dimers, and when they try to interact with wild-type, maybe the whole complex isn't functional. So the transcription factor doesn't dimerize, doesn't go into the nucleus, and doesn't activate genes. So the phenotype is loss of function.\n\nLooking again at the options, D says protein aggregation and loss.",
          "text2": "Wait, going back. Let's think about dominant-negative mutations. In this case, the mutant Y would form a non-functional dimer when paired with wild-type. Because the dimerization domain is messed up, they can't form active dimers. So the Y mutant prevents the wild-type from functioning. So in a heterozygote, the wild-type allele is expressed but can't form active dimers because it's either binding to the mutant Y or the mutant Y is preventing the proper folding.\n\nSo the presence of Y leads to the inability of the transcription factor to dimerize, which means it can't enter the nucleus and activate gene transcription. So the phenotype would be a loss-of-function.\n\nLooking at the options, I think D says protein aggregation and loss of function. Or B says protein degradation. But I'm not sure.",
          "score": 0.9209001064300537
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c3",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Alternatively, perhaps the presence of Y causes the mutant protein to form non-functional dimers, leading to loss of function. So the dominant-negative effect is causing the loss. So looking at the options, which one matches this scenario.\n\nOption D: Aggregation and loss. I'm not sure about the aggregation part.",
          "text2": "Wait, but how does dominant-negative work? The mutant subunits might form nonfunctional dimers with wild-type subunits. So when Y is present, any wild-type subunits would pair with Y, making a dimer that can't function. So the transactivation doesn't happen, no gene expression.\n\nSo the effect is that the transcription factor can't function because the dimerization is impaired, leading to loss of function. \n\nLooking back at the options, which one fits this? Let's see:\n\nOption D says protein aggregation and loss. If Y causes the proteins to aggregate, then they're not functional, so the phenotype is loss.\n\nOption B says protein degradation. I'm not sure if Y would lead to degradation. It could, but I think dominant-negative often doesn't destroy the protein but stops it from working, perhaps by causing misfolding or improper interactions.",
          "score": 0.8802888989448547
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c6",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Wait, what's the molecular phenotype? The question says which molecular phenotype is observed. So options are about what molecular changes occur.\n\nOption D says protein aggregation and loss of function. So if the mutant Y leads to the protein aggregating, and thus not functioning, that would fit.",
          "text2": "Alternatively, perhaps the presence of Y leads to the inability of the wild-type to function. So the cells can't transcribe the gene, leading to loss of function. So the phenotype would be loss-of-function.\n\nLooking again at the options:\n\nOption B: protein degradation and loss of wild-type allele function. Not sure if degradation is a factor here.\n\nOption D: protein aggregation and loss of function. Aggregation might happen if the mutant and wild-type can't form correct dimers, so they aggregate, leading to no functional protein.\n\nSo the molecular phenotype would be that the proteins can't form dimers (so no dimerization) and the overall function is lost. So which option matches that.\n\nOption D says protein aggregation and loss of function. That makes sense. Or, if it's about dimerization, maybe option C is about loss of dimerization, but the phenotype would be loss of function, so option C is 'wild-type phenotype' which doesn't fit.",
          "score": 0.875187873840332
        },
        {
          "chain1_id": "q158_c8",
          "chain2_id": "q158_c1",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "text2": "Wait, the question is about the molecular phenotype when Y is present. So in the cell, the mutant Y protein is present. Since it\u2019s dominant-negative, when the mutant and wild-type proteins try to dimerize, they form non-functional dimers because Y is in the dimerization domain.\n\nSo the mutant Y would prevent the wild-type from dimerizing correctly. So the result is that the transcription factor can't function because the dimerization doesn't happen. So the phenotype is loss-of-function.\n\nLooking back at the options, which match this.\n\nOption D says protein aggregation and loss-of-function. I'm not sure if the proteins aggregate, but in dominant-negative situations, the mutant might interfere with the wild-type, leading to non-functional dimers. So more likely, the phenotype is loss-of-function.\n\nLooking at the options again:\n\nOption B: Protein degradation and loss of wild-type. I'm not sure about degradation. Option D says aggregation and loss.",
          "score": 0.9468410015106201
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c7",
          "thought1_idx": 8,
          "thought2_idx": 8,
          "text1": "Wait, the question says the mutation Y is in the dimerization domain and is dominant-negative. So when Y is present, even in a heterozygous state, the mutant protein interferes with the wild-type. So the wild-type allele is not expressed, or its function is blocked.\n\nIn this case, when the inactive transcription factor is phosphorylated, it should dimerize. But if Y is present, the dimerization can't happen properly, so the activated protein can't form dimers. So the dimerization is prevented, which means the transcription factor doesn't go into the nucleus, so gene transcription doesn't occur. So the function is lost.\n\nLooking at the options, which is about the molecular phenotype.\n\nOption D says protein aggregation and loss of function. So if the mutant Y subunits can't dimerize, perhaps they form aggregates or multimers that aren't functional. So the presence of Y leads to protein aggregation and the transcription factor can't function, leading to loss of function.",
          "text2": "Wait, but the question is about the molecular phenotype. So, in the presence of Y, what's happening?\n\nIf the transcription factor can't dimerize, then even if the rest of the process (phosphorylation, moving into nucleus) happens, the dimer is necessary for function. So without dimerization, the transcription factor can't function, leading to loss of function.\n\nBut looking at the options, the question is about the mutation Y's effect. So, Y is a dominant-negative in the dimerization domain. So, the presence of Y would prevent proper dimer formation, perhaps leading to the inability of the transcription factor to function.\n\nWhich option reflects this? Let's look again at the options.\n\nOption D says protein aggregation and loss of function. That would imply that the proteins are clumping together and not functioning, leading to a loss.\n\nOption B says protein degradation and loss of function of wild-type. I'm less sure about this. Degradation because of Y? Maybe the mutant Y is marked for degradation, but would that degrade the wild-type proteins too?",
          "score": 0.9459652900695801
        },
        {
          "chain1_id": "q158_c5",
          "chain2_id": "q158_c3",
          "thought1_idx": 8,
          "thought2_idx": 8,
          "text1": "Alternatively, the presence of Y in the dimerization domain may prevent the protein from forming dimers. So, even if a wild-type allele is present, the mutant Y would cause the proteins not to form dimers, leading to a loss of function. So the molecular phenotype would be the inability to dimerize, leading to loss of function.\n\nLooking at the options, which option says loss of dimerization and loss of function.",
          "text2": "Alternatively, the mutation Y is causing the mutant protein to interfere in dimerization, so dimerization doesn't occur. So the molecular phenotype is loss of dimerization, which would lead to loss of function.\n\nBut the options don't have an option that directly states loss of dimerization. Let me check the options again.\n\nOptions:\n\nA) Change of protein conformation and gain-of-function.\n\nB) Protein degradation and loss-of-function of the wild-type allele.\n\nC) Loss of protein dimerization and wild-type phenotype.\n\nD) Protein aggregation and loss-of-function phenotype.\n\nHmm. From what I understand, the presence of Y (dominant-negative) would lead to the inability to form functional dimers. So the molecular change is loss of dimerization, which is option C's first part. But option C's second part says wild-type phenotype, which doesn't make sense. Because if dimerization doesn't happen, the transcription factor can't function, so the phenotype is loss of function, not wild-type.",
          "score": 0.8863629102706909
        },
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c8",
          "thought1_idx": 8,
          "thought2_idx": 5,
          "text1": "Wait, but the question is about the presence of Y. The molecular phenotype is what happens to the proteins.\n\nIf Y is a dominant-negative, then the mutant and wild-type form non-functional dimers. So the proteins are present but not active.\n\nSo would that lead to protein degradation? Or would they just not function?\n\nIn most cases, if the protein can't fold properly, it might be targeted for degradation via the proteasome. But in the case of dominant-negative, the WT and mutant might form dimers that are not functional but are still present.",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.8568181395530701
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c5",
          "thought1_idx": 10,
          "thought2_idx": 9,
          "text1": "Wait, the options don't include \"loss of dimerization\" as a separate choice, but option C says \"loss of protein dimerization and wild-type phenotype\", which doesn't make sense because the function would be lost, not wild-type.\n\nHmm, perhaps I'm overcomplicating this. Let's think about what each option describes.\n\nOption D: protein aggregation and loss of function. So the protein can't dimerize properly, leading to aggregation (like inclusion bodies or something) and the function is lost.",
          "text2": "Wait, none of the options directly mention dimerization. Let me check the options again.\n\nOption A: change of conformation and gain of function.\n\nOption B: protein degradation and loss of function.\n\nOption C: loss of dimerization and wild-type phenotype.\n\nOption D: protein aggregation and loss of function.\n\nHmm, none of the options directly say 'loss of dimerization and loss of function.' So perhaps the closest is D, where the protein can't form dimers, leading to aggregation.",
          "score": 0.8725942373275757
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c2",
          "thought1_idx": 10,
          "thought2_idx": 9,
          "text1": "Another angle: the wild-type allele's function being lost. If Y is dominant-negative, it inhibits the wild-type allele, making its protein unable to function. So the wild-type protein's function is lost because it's being interfered with by Y.\n\nBut if the wild-type is present but can't function due to Y, then the overall effect is loss of function, but is the protein being degraded or just non-functional?",
          "text2": "Wait, but option B is protein degradation and loss of wild-type function. That would happen if the mutant Y somehow caused the wild-type proteins to be targeted for degradation. But in dominant-negative scenarios, the proteins are usually not broken down but just non-functional.\n\nSo between options D and B. I think the key here is that the dominant-negative mutation Y would cause the wild-type proteins to be unable to function because they form non-functional dimers with Y. So the presence of Y would lead to the inability of the wild-type allele to function. However, the proteins themselves may not be degraded; they just can't form the right structures.",
          "score": 0.8717443943023682
        },
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c2",
          "thought1_idx": 11,
          "thought2_idx": 5,
          "text1": "Another angle: in a dominant-negative scenario, the mutant interferes with the function of the normal allele. So when the person is heterozygous (wild-type and Y), the Y allele's product (which is mutant) will interfere with the wild-type product's ability to function.\n\nSince Y is in the dimerization domain, when the two subunits try to come together, perhaps the mutant Y prevents proper dimerization. So the wild-type can't form functional dimers, leading to the inability to translocate to the nucleus and activate transcription.\n\nSo the result would be that the transcription factor doesn't function, leading to a loss of function. So the phenotype is loss of function.\n\nLooking at the options, options B, C, D have loss of function. So the question is about the molecular phenotype. What's happening to the proteins?\n\nOption D says protein aggregation and loss of function. So perhaps the proteins can't form the proper dimers and instead form aggregates.",
          "text2": "Wait, the question is about the molecular phenotype. So what's happening at the molecular level?\n\nDominant-negative mutations often lead to the formation of non-functional complexes. So the presence of Y would mean that the wild-type allele's product (the transcription factor) can't form functional dimers because they are associating with the mutant Y subunits which prevent proper dimerization.\n\nSo the wild-type proteins are present but can't function because they're stuck in non-functional dimers. The mutant Y doesn't form functional dimers on its own, but can interfere with the wild-type.\n\nSo the overall result is that the transcription factor can't function, leading to loss of gene transcription. So the phenotype would be loss-of-function.\n\nLooking at the options again:\n\nOption D says protein aggregation and loss-of-function. If the mutant prevents proper dimerization, perhaps the proteins don't aggregate but are just unable to form the correct structures.",
          "score": 0.9457690715789795
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c5",
          "thought1_idx": 12,
          "thought2_idx": 2,
          "text1": "Wait, option C says loss of dimerization and wild-type phenotype. That doesn't make sense. If dimerization is lost, the phenotype can't be wild-type. So that's not correct.\n\nSo, back to the options.\n\nThe Y mutation is in the dimerization domain and is dominant-negative. So the mutant subunits would interfere with the wild-type's ability to dimerize.\n\nIn a heterozygous state, there are some wild-type and some mutant proteins.\n\nWhen the mutant proteins are present, they might form non-functional dimers with the wild-type, or perhaps prevent the wild-type from finding a partner to dimerize with.\n\nSo, the wild-type protein's ability to dimerize is blocked, so the transcription factor can't function. Thus, the phenotype is a loss of function.\n\nLooking at the options, which have a loss of function.\n\nOption B: protein degradation and loss of wild-type function.\n\nOption D: protein aggregation and loss.\n\nBut I think in dominant-negative, the proteins are present but non-functional. So no degradation, but they can't form functional dimers.\n\nSo perhaps the molecular phenotype is that the proteins can't dimerize, leading to loss of function.\n\nSo, looking for an option that says loss of dimerization and loss of function. But none of the options directly state that.",
          "text2": "Wait, going back. Let's think about dominant-negative mutations. In this case, the mutant Y would form a non-functional dimer when paired with wild-type. Because the dimerization domain is messed up, they can't form active dimers. So the Y mutant prevents the wild-type from functioning. So in a heterozygote, the wild-type allele is expressed but can't form active dimers because it's either binding to the mutant Y or the mutant Y is preventing the proper folding.\n\nSo the presence of Y leads to the inability of the transcription factor to dimerize, which means it can't enter the nucleus and activate gene transcription. So the phenotype would be a loss-of-function.\n\nLooking at the options, I think D says protein aggregation and loss of function. Or B says protein degradation. But I'm not sure.",
          "score": 0.9505887627601624
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c4",
          "thought1_idx": 13,
          "thought2_idx": 2,
          "text1": "Wait, option C says loss of dimerization and wild-type. That's contradictory. So it's not that.\n\nOption D: aggregation and loss. Maybe the mutant Y causes the proteins to aggregate, which would prevent them from functioning.",
          "text2": "Wait, if the proteins can't dimerize, the function is lost, so the phenotype would be loss-of-function, not wild-type. So C's description seems conflicting. It says the phenotype is wild-type, but if dimerization doesn't happen, the function is lost. So C is probably incorrect.\n\nOption D: Protein aggregation and loss-of-function. Well, if the mutant Y can't dimerize correctly, maybe it forms aggregates. Like, misfolded proteins sometimes aggregate. So the presence of Y could lead to aggregation (misfolded proteins sticking together), and since the dimerization doesn't happen, the function is lost. So D seems possible.",
          "score": 0.9136219024658203
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c1",
          "thought1_idx": 15,
          "thought2_idx": 4,
          "text1": "Alternatively, if the dimerization is critical for nuclear import, and the mutant Y prevents this, the proteins might remain in the cytoplasm and not enter the nucleus, leading to loss of function. But this doesn't necessarily cause protein aggregation.\n\nSo perhaps the molecular phenotype is that the proteins can't dimerize, so they're stuck as monomers and can't function. So the presence of Y would lead to loss of dimerization, thus loss of function.\n\nLooking back at the options, option D involves protein aggregation, which I'm not sure about. Option B is about degradation. Option C says loss of dimerization and wild-type phenotype, which doesn't make sense because the phenotype would be loss.",
          "text2": "Alternatively, when the mutant Y is present, the normal protein can't form dimers, so they might not be able to enter the nucleus. So the transcription factor doesn't work, leading to loss of function.\n\nSo which option aligns with this?\n\nOption D says protein aggregation and loss-of-function. But does the mutant cause aggregation? Or does it just prevent dimerization?",
          "score": 0.9081236124038696
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c1",
          "thought1_idx": 16,
          "thought2_idx": 12,
          "text1": "Wait, but the question is about the presence of mutation Y. The key is that Y is dominant-negative, so the heterozygous state leads to the mutant allele preventing the wild-type from functioning.\n\nSo, in terms of the effect on the protein:\n\n- The mutant Y can't dimerize, so when it's present, it can't form the necessary dimers, thus the transcription factor can't function. So the phenotype is loss of function.\n\nLooking back at the options, D says protein aggregation and loss of function. This would fit if the mutant proteins aggregate, but I'm not certain.",
          "text2": "Wait, option C says loss of dimerization and wild-type phenotype. That doesn't make sense. If dimerization is lost, the phenotype can't be wild-type. So that's not correct.\n\nSo, back to the options.\n\nThe Y mutation is in the dimerization domain and is dominant-negative. So the mutant subunits would interfere with the wild-type's ability to dimerize.\n\nIn a heterozygous state, there are some wild-type and some mutant proteins.\n\nWhen the mutant proteins are present, they might form non-functional dimers with the wild-type, or perhaps prevent the wild-type from finding a partner to dimerize with.\n\nSo, the wild-type protein's ability to dimerize is blocked, so the transcription factor can't function. Thus, the phenotype is a loss of function.\n\nLooking at the options, which have a loss of function.\n\nOption B: protein degradation and loss of wild-type function.\n\nOption D: protein aggregation and loss.\n\nBut I think in dominant-negative, the proteins are present but non-functional. So no degradation, but they can't form functional dimers.\n\nSo perhaps the molecular phenotype is that the proteins can't dimerize, leading to loss of function.\n\nSo, looking for an option that says loss of dimerization and loss of function. But none of the options directly state that.",
          "score": 0.939691424369812
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c8",
          "thought1_idx": 17,
          "thought2_idx": 5,
          "text1": "Wait, but because it's a dominant-negative, the presence of Y in the cell would affect the function of the wild-type. If the Y subunits can still bind to wild-type subunits, then the resulting dimers would be non-functional. So the wild-type subunits are present but can't form functional dimers because they're stuck with the mutant Y.\n\nSo the result is that the transcription factor can't function, leading to loss of function.\n\nSo the molecular phenotype would involve the inability to dimerize, leading to loss of function. But looking at the options, none of them directly say that. The options are about the proteins\u2014either their conformation, aggregation, degradation, etc.\n\nIn the presence of Y, the proteins can't form dimers, so they don't perform their function. But what about their presence in the cell? Do they aggregate?",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.9297323226928711
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c8",
          "thought1_idx": 19,
          "thought2_idx": 2,
          "text1": "Alternatively, the mutant Y could cause the entire complex to be non-functional, leading to the protein not being active, but perhaps the proteins are still present.\n\nSo, the dominant-negative effect would mean that the presence of Y prevents the normal function of the transcription factor. So the outcome is that the transcription factor can't function, leading to loss of function.\n\nWhich options have loss of function? A is gain, so no. B and D are loss. C is wild-type.\n\nSo between B and D.\n\nOption B: protein degradation and loss of wild-type. So, the mutant Y's protein is being degraded, perhaps due to misfolding. But would that affect the wild-type? Maybe not directly. But if the mutant Y is causing the wild-type proteins to be unable to form dimers, perhaps the wild-type proteins are stuck in the cytoplasm and get degraded.",
          "text2": "Wait, but what's the effect of dominant-negative in this case? The mutant Y would interfere with the dimerization of the wild-type. So the presence of Y would mean that even the wild-type subunits can't form active dimers because they pair with the mutant Y, which can't form proper dimers. So the result is that the transcription factor doesn't function, leading to a loss of function.\n\nLooking back at the options, in D, the proteins aggregate and function is lost.",
          "score": 0.916894257068634
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c4",
          "thought1_idx": 21,
          "thought2_idx": 15,
          "text1": "Alternatively, perhaps the mutation Y in the dimerization domain doesn't allow proper dimerization, so the proteins can't form the necessary structures, leading to a failure in their function. So the molecular change is the inability to dimerize, but the options don't have that. So I'm a bit stuck.",
          "text2": "Alternatively, perhaps the dominant-negative Y mutant doesn't allow any functional dimers, but the protein doesn't aggregate. So the molecular change is loss of dimerization. But none of the options directly state that.",
          "score": 0.8754709362983704
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c3",
          "thought1_idx": 22,
          "thought2_idx": 3,
          "text1": "Wait, another angle: when a protein is dominant-negative, it often means that it interferes with the normal function of the wild-type protein. So, in this case, the Y mutant might form non-functional dimers with the wild-type, preventing them from functioning. So the overall effect is that the transcription factor can't function, leading to loss of function.\n\nBut the question is about the molecular phenotype. So, what's happening at the molecular level?\n\nOption D says protein aggregation and loss of function.",
          "text2": "Wait, but how does dominant-negative work? The mutant subunits might form nonfunctional dimers with wild-type subunits. So when Y is present, any wild-type subunits would pair with Y, making a dimer that can't function. So the transactivation doesn't happen, no gene expression.\n\nSo the effect is that the transcription factor can't function because the dimerization is impaired, leading to loss of function. \n\nLooking back at the options, which one fits this? Let's see:\n\nOption D says protein aggregation and loss. If Y causes the proteins to aggregate, then they're not functional, so the phenotype is loss.\n\nOption B says protein degradation. I'm not sure if Y would lead to degradation. It could, but I think dominant-negative often doesn't destroy the protein but stops it from working, perhaps by causing misfolding or improper interactions.",
          "score": 0.9446625113487244
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c8",
          "thought1_idx": 26,
          "thought2_idx": 5,
          "text1": "Alternatively, perhaps the dominant-negative Y causes the mutant protein to aggregate, leading to the loss of function. So the molecular change is aggregation, and the phenotype is loss of function. That would make option D correct.\n\nBut I'm not sure if aggregation is the correct molecular change. Maybe the presence of Y doesn't cause the proteins to aggregate but just prevents dimerization.",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.8950203061103821
        },
        {
          "chain1_id": "q158_c3",
          "chain2_id": "q158_c6",
          "thought1_idx": 30,
          "thought2_idx": 5,
          "text1": "Alternatively, perhaps the answer is D. Because when a dominant-negative mutation is present, the mutant proteins can interfere with the wild-type, perhaps leading to the formation of aggregates (misfolded proteins) which can't function, thus leading to loss of function.\n\nSo in that case, the molecular phenotype would involve aggregation, making option D correct.",
          "text2": "Another approach: dominant-negative in the dimerization domain. When a dominant-negative mutation is present, the mutant protein can't function on its own, but can disrupt the function of the wild-type protein.\n\nSo for example, suppose the protein normally forms homo-dimers. If one subunit is mutant Y, it can't form a proper dimer. If the mutant Y binds to the wild-type, it might form a hetero-dimer that doesn't function. So the presence of Y would mean that even when the wild-type is present, the overall activity is reduced because many of the dimers are non-functional.\n\nIn this case, dimerization is affected, leading to a loss of function. So the molecular phenotype would be that the proteins can't dimerize (so loss of dimerization) and the phenotype is loss of function.\n\nLooking at the options again:\n\nOption D: protein aggregation and loss of function. So if the proteins can't dimerize, they might form aggregates? Or perhaps the mutant is not properly folded and aggregates.",
          "score": 0.8662033081054688
        }
      ],
      "num_detected": 21,
      "num_same_answer": 21,
      "same_answer_perc": 100.0
    },
    "0.9": {
      "detected_pairs": [
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c7",
          "thought1_idx": 2,
          "thought2_idx": 2,
          "text1": "Alternatively, maybe the wild-type and mutant can't form a proper dimer, so they're not functional. So the cell's transcription factor activity goes down, leading to a loss-of-function phenotype.\n\nOption B says protein degradation. I'm not sure if Y causes the proteins to degrade. If the mutant Y is not properly processed, maybe it gets degraded, but the wild-type might be as well if it's bound. Or perhaps the mutant doesn't interfere with degradation.",
          "text2": "Wait, why would the wild-type allele be degraded? I'm not sure. The mutation Y is dominant-negative, so it affects the wild-type's ability to function, but I don't think it causes the protein to degrade. Unless the mutant proteins aggregate and cause the cell to degrade them.\n\nOption C: Loss of dimerization and wild-type phenotype. No, because if dimerization is lost, the transcription factor can't function, so the phenotype would be a loss of function, not wild-type.\n\nOption D: Protein aggregation and loss-of-function. Aggregation might happen if the mutant proteins form faulty structures, leading to the formation of aggregates. If the proteins can't dimerize correctly, they might clump together, and the cell might degrade them. That would prevent the transcription factor from working, leading to a loss of function.",
          "score": 0.9003003835678101
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c5",
          "thought1_idx": 3,
          "thought2_idx": 2,
          "text1": "Wait, but the question is about the presence of mutation Y. So in a heterozygous state, you have some wild-type and some Y mutant proteins. The Y mutant can't form dimers, and when they try to interact with wild-type, maybe the whole complex isn't functional. So the transcription factor doesn't dimerize, doesn't go into the nucleus, and doesn't activate genes. So the phenotype is loss of function.\n\nLooking again at the options, D says protein aggregation and loss.",
          "text2": "Wait, going back. Let's think about dominant-negative mutations. In this case, the mutant Y would form a non-functional dimer when paired with wild-type. Because the dimerization domain is messed up, they can't form active dimers. So the Y mutant prevents the wild-type from functioning. So in a heterozygote, the wild-type allele is expressed but can't form active dimers because it's either binding to the mutant Y or the mutant Y is preventing the proper folding.\n\nSo the presence of Y leads to the inability of the transcription factor to dimerize, which means it can't enter the nucleus and activate gene transcription. So the phenotype would be a loss-of-function.\n\nLooking at the options, I think D says protein aggregation and loss of function. Or B says protein degradation. But I'm not sure.",
          "score": 0.9209001064300537
        },
        {
          "chain1_id": "q158_c8",
          "chain2_id": "q158_c1",
          "thought1_idx": 5,
          "thought2_idx": 3,
          "text1": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "text2": "Wait, the question is about the molecular phenotype when Y is present. So in the cell, the mutant Y protein is present. Since it\u2019s dominant-negative, when the mutant and wild-type proteins try to dimerize, they form non-functional dimers because Y is in the dimerization domain.\n\nSo the mutant Y would prevent the wild-type from dimerizing correctly. So the result is that the transcription factor can't function because the dimerization doesn't happen. So the phenotype is loss-of-function.\n\nLooking back at the options, which match this.\n\nOption D says protein aggregation and loss-of-function. I'm not sure if the proteins aggregate, but in dominant-negative situations, the mutant might interfere with the wild-type, leading to non-functional dimers. So more likely, the phenotype is loss-of-function.\n\nLooking at the options again:\n\nOption B: Protein degradation and loss of wild-type. I'm not sure about degradation. Option D says aggregation and loss.",
          "score": 0.9468410015106201
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c3",
          "thought1_idx": 7,
          "thought2_idx": 2,
          "text1": "Wait, the question says the mutation Y is in the dimerization domain. So when the mutant is present, it can't dimerize, but perhaps it can interfere with the wild-type's ability to dimerize. So the wild-type proteins can't form dimers because some of them are binding to the mutant, which can't form proper dimers.\n\nSo the wild-type proteins are unable to function because their dimerization is compromised.\n\nSo, the result is that the transcription factor doesn't function. So the phenotype is loss of function, but what about the proteins themselves?\n\nDo the proteins aggregate? Maybe, but I'm not certain.",
          "text2": "Wait, if the wild-type can't dimerize because of Y, then the transcription factor isn't functional. So the phenotype should be loss of function. So wild-type phenotype wouldn't make sense here. The wild-type wouldn't function because the dimer can't form. So perhaps the phenotype is more like a loss.\n\nOption D: Protein aggregation and loss of function. Aggregation might happen if the mutant forms misfolded proteins that stick together, which could prevent them from working. So if Y causes the proteins to aggregate, then they can't dimerize properly or function. That would lead to loss of function.",
          "score": 0.9095713496208191
        },
        {
          "chain1_id": "q158_c4",
          "chain2_id": "q158_c7",
          "thought1_idx": 8,
          "thought2_idx": 8,
          "text1": "Wait, the question says the mutation Y is in the dimerization domain and is dominant-negative. So when Y is present, even in a heterozygous state, the mutant protein interferes with the wild-type. So the wild-type allele is not expressed, or its function is blocked.\n\nIn this case, when the inactive transcription factor is phosphorylated, it should dimerize. But if Y is present, the dimerization can't happen properly, so the activated protein can't form dimers. So the dimerization is prevented, which means the transcription factor doesn't go into the nucleus, so gene transcription doesn't occur. So the function is lost.\n\nLooking at the options, which is about the molecular phenotype.\n\nOption D says protein aggregation and loss of function. So if the mutant Y subunits can't dimerize, perhaps they form aggregates or multimers that aren't functional. So the presence of Y leads to protein aggregation and the transcription factor can't function, leading to loss of function.",
          "text2": "Wait, but the question is about the molecular phenotype. So, in the presence of Y, what's happening?\n\nIf the transcription factor can't dimerize, then even if the rest of the process (phosphorylation, moving into nucleus) happens, the dimer is necessary for function. So without dimerization, the transcription factor can't function, leading to loss of function.\n\nBut looking at the options, the question is about the mutation Y's effect. So, Y is a dominant-negative in the dimerization domain. So, the presence of Y would prevent proper dimer formation, perhaps leading to the inability of the transcription factor to function.\n\nWhich option reflects this? Let's look again at the options.\n\nOption D says protein aggregation and loss of function. That would imply that the proteins are clumping together and not functioning, leading to a loss.\n\nOption B says protein degradation and loss of function of wild-type. I'm less sure about this. Degradation because of Y? Maybe the mutant Y is marked for degradation, but would that degrade the wild-type proteins too?",
          "score": 0.9459652900695801
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c7",
          "thought1_idx": 11,
          "thought2_idx": 9,
          "text1": "Alternatively, perhaps the mutant Y proteins can't dimerize and form some aggregates, which could lead to the loss of function.",
          "text2": "Alternatively, perhaps the presence of Y leads to the mutant proteins and wild-type proteins not forming a functional dimer, so the proteins might be stuck in an incomplete state and get degraded.",
          "score": 0.9115155935287476
        },
        {
          "chain1_id": "q158_c6",
          "chain2_id": "q158_c2",
          "thought1_idx": 11,
          "thought2_idx": 5,
          "text1": "Another angle: in a dominant-negative scenario, the mutant interferes with the function of the normal allele. So when the person is heterozygous (wild-type and Y), the Y allele's product (which is mutant) will interfere with the wild-type product's ability to function.\n\nSince Y is in the dimerization domain, when the two subunits try to come together, perhaps the mutant Y prevents proper dimerization. So the wild-type can't form functional dimers, leading to the inability to translocate to the nucleus and activate transcription.\n\nSo the result would be that the transcription factor doesn't function, leading to a loss of function. So the phenotype is loss of function.\n\nLooking at the options, options B, C, D have loss of function. So the question is about the molecular phenotype. What's happening to the proteins?\n\nOption D says protein aggregation and loss of function. So perhaps the proteins can't form the proper dimers and instead form aggregates.",
          "text2": "Wait, the question is about the molecular phenotype. So what's happening at the molecular level?\n\nDominant-negative mutations often lead to the formation of non-functional complexes. So the presence of Y would mean that the wild-type allele's product (the transcription factor) can't form functional dimers because they are associating with the mutant Y subunits which prevent proper dimerization.\n\nSo the wild-type proteins are present but can't function because they're stuck in non-functional dimers. The mutant Y doesn't form functional dimers on its own, but can interfere with the wild-type.\n\nSo the overall result is that the transcription factor can't function, leading to loss of gene transcription. So the phenotype would be loss-of-function.\n\nLooking at the options again:\n\nOption D says protein aggregation and loss-of-function. If the mutant prevents proper dimerization, perhaps the proteins don't aggregate but are just unable to form the correct structures.",
          "score": 0.9457690715789795
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c5",
          "thought1_idx": 12,
          "thought2_idx": 2,
          "text1": "Wait, option C says loss of dimerization and wild-type phenotype. That doesn't make sense. If dimerization is lost, the phenotype can't be wild-type. So that's not correct.\n\nSo, back to the options.\n\nThe Y mutation is in the dimerization domain and is dominant-negative. So the mutant subunits would interfere with the wild-type's ability to dimerize.\n\nIn a heterozygous state, there are some wild-type and some mutant proteins.\n\nWhen the mutant proteins are present, they might form non-functional dimers with the wild-type, or perhaps prevent the wild-type from finding a partner to dimerize with.\n\nSo, the wild-type protein's ability to dimerize is blocked, so the transcription factor can't function. Thus, the phenotype is a loss of function.\n\nLooking at the options, which have a loss of function.\n\nOption B: protein degradation and loss of wild-type function.\n\nOption D: protein aggregation and loss.\n\nBut I think in dominant-negative, the proteins are present but non-functional. So no degradation, but they can't form functional dimers.\n\nSo perhaps the molecular phenotype is that the proteins can't dimerize, leading to loss of function.\n\nSo, looking for an option that says loss of dimerization and loss of function. But none of the options directly state that.",
          "text2": "Wait, going back. Let's think about dominant-negative mutations. In this case, the mutant Y would form a non-functional dimer when paired with wild-type. Because the dimerization domain is messed up, they can't form active dimers. So the Y mutant prevents the wild-type from functioning. So in a heterozygote, the wild-type allele is expressed but can't form active dimers because it's either binding to the mutant Y or the mutant Y is preventing the proper folding.\n\nSo the presence of Y leads to the inability of the transcription factor to dimerize, which means it can't enter the nucleus and activate gene transcription. So the phenotype would be a loss-of-function.\n\nLooking at the options, I think D says protein aggregation and loss of function. Or B says protein degradation. But I'm not sure.",
          "score": 0.9505887627601624
        },
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c4",
          "thought1_idx": 13,
          "thought2_idx": 2,
          "text1": "Wait, option C says loss of dimerization and wild-type. That's contradictory. So it's not that.\n\nOption D: aggregation and loss. Maybe the mutant Y causes the proteins to aggregate, which would prevent them from functioning.",
          "text2": "Wait, if the proteins can't dimerize, the function is lost, so the phenotype would be loss-of-function, not wild-type. So C's description seems conflicting. It says the phenotype is wild-type, but if dimerization doesn't happen, the function is lost. So C is probably incorrect.\n\nOption D: Protein aggregation and loss-of-function. Well, if the mutant Y can't dimerize correctly, maybe it forms aggregates. Like, misfolded proteins sometimes aggregate. So the presence of Y could lead to aggregation (misfolded proteins sticking together), and since the dimerization doesn't happen, the function is lost. So D seems possible.",
          "score": 0.9136219024658203
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c1",
          "thought1_idx": 15,
          "thought2_idx": 4,
          "text1": "Alternatively, if the dimerization is critical for nuclear import, and the mutant Y prevents this, the proteins might remain in the cytoplasm and not enter the nucleus, leading to loss of function. But this doesn't necessarily cause protein aggregation.\n\nSo perhaps the molecular phenotype is that the proteins can't dimerize, so they're stuck as monomers and can't function. So the presence of Y would lead to loss of dimerization, thus loss of function.\n\nLooking back at the options, option D involves protein aggregation, which I'm not sure about. Option B is about degradation. Option C says loss of dimerization and wild-type phenotype, which doesn't make sense because the phenotype would be loss.",
          "text2": "Alternatively, when the mutant Y is present, the normal protein can't form dimers, so they might not be able to enter the nucleus. So the transcription factor doesn't work, leading to loss of function.\n\nSo which option aligns with this?\n\nOption D says protein aggregation and loss-of-function. But does the mutant cause aggregation? Or does it just prevent dimerization?",
          "score": 0.9081236124038696
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c1",
          "thought1_idx": 16,
          "thought2_idx": 12,
          "text1": "Wait, but the question is about the presence of mutation Y. The key is that Y is dominant-negative, so the heterozygous state leads to the mutant allele preventing the wild-type from functioning.\n\nSo, in terms of the effect on the protein:\n\n- The mutant Y can't dimerize, so when it's present, it can't form the necessary dimers, thus the transcription factor can't function. So the phenotype is loss of function.\n\nLooking back at the options, D says protein aggregation and loss of function. This would fit if the mutant proteins aggregate, but I'm not certain.",
          "text2": "Wait, option C says loss of dimerization and wild-type phenotype. That doesn't make sense. If dimerization is lost, the phenotype can't be wild-type. So that's not correct.\n\nSo, back to the options.\n\nThe Y mutation is in the dimerization domain and is dominant-negative. So the mutant subunits would interfere with the wild-type's ability to dimerize.\n\nIn a heterozygous state, there are some wild-type and some mutant proteins.\n\nWhen the mutant proteins are present, they might form non-functional dimers with the wild-type, or perhaps prevent the wild-type from finding a partner to dimerize with.\n\nSo, the wild-type protein's ability to dimerize is blocked, so the transcription factor can't function. Thus, the phenotype is a loss of function.\n\nLooking at the options, which have a loss of function.\n\nOption B: protein degradation and loss of wild-type function.\n\nOption D: protein aggregation and loss.\n\nBut I think in dominant-negative, the proteins are present but non-functional. So no degradation, but they can't form functional dimers.\n\nSo perhaps the molecular phenotype is that the proteins can't dimerize, leading to loss of function.\n\nSo, looking for an option that says loss of dimerization and loss of function. But none of the options directly state that.",
          "score": 0.939691424369812
        },
        {
          "chain1_id": "q158_c2",
          "chain2_id": "q158_c8",
          "thought1_idx": 17,
          "thought2_idx": 5,
          "text1": "Wait, but because it's a dominant-negative, the presence of Y in the cell would affect the function of the wild-type. If the Y subunits can still bind to wild-type subunits, then the resulting dimers would be non-functional. So the wild-type subunits are present but can't form functional dimers because they're stuck with the mutant Y.\n\nSo the result is that the transcription factor can't function, leading to loss of function.\n\nSo the molecular phenotype would involve the inability to dimerize, leading to loss of function. But looking at the options, none of them directly say that. The options are about the proteins\u2014either their conformation, aggregation, degradation, etc.\n\nIn the presence of Y, the proteins can't form dimers, so they don't perform their function. But what about their presence in the cell? Do they aggregate?",
          "text2": "Wait, the question states that Y is a dominant-negative, which usually means the mutant protein interferes with the normal function of the wild-type. So in this case, the mutant Y would prevent proper dimerization. So the proteins can't form functional dimers. If they can't dimerize, they don't enter the nucleus, so the transcription factor doesn't work, leading to loss of function.\n\nSo the molecular phenotype would be that the proteins can't dimerize, and the function is lost. Looking at the options, option D says protein aggregation and loss of function.",
          "score": 0.9297323226928711
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c8",
          "thought1_idx": 19,
          "thought2_idx": 2,
          "text1": "Alternatively, the mutant Y could cause the entire complex to be non-functional, leading to the protein not being active, but perhaps the proteins are still present.\n\nSo, the dominant-negative effect would mean that the presence of Y prevents the normal function of the transcription factor. So the outcome is that the transcription factor can't function, leading to loss of function.\n\nWhich options have loss of function? A is gain, so no. B and D are loss. C is wild-type.\n\nSo between B and D.\n\nOption B: protein degradation and loss of wild-type. So, the mutant Y's protein is being degraded, perhaps due to misfolding. But would that affect the wild-type? Maybe not directly. But if the mutant Y is causing the wild-type proteins to be unable to form dimers, perhaps the wild-type proteins are stuck in the cytoplasm and get degraded.",
          "text2": "Wait, but what's the effect of dominant-negative in this case? The mutant Y would interfere with the dimerization of the wild-type. So the presence of Y would mean that even the wild-type subunits can't form active dimers because they pair with the mutant Y, which can't form proper dimers. So the result is that the transcription factor doesn't function, leading to a loss of function.\n\nLooking back at the options, in D, the proteins aggregate and function is lost.",
          "score": 0.916894257068634
        },
        {
          "chain1_id": "q158_c7",
          "chain2_id": "q158_c3",
          "thought1_idx": 22,
          "thought2_idx": 3,
          "text1": "Wait, another angle: when a protein is dominant-negative, it often means that it interferes with the normal function of the wild-type protein. So, in this case, the Y mutant might form non-functional dimers with the wild-type, preventing them from functioning. So the overall effect is that the transcription factor can't function, leading to loss of function.\n\nBut the question is about the molecular phenotype. So, what's happening at the molecular level?\n\nOption D says protein aggregation and loss of function.",
          "text2": "Wait, but how does dominant-negative work? The mutant subunits might form nonfunctional dimers with wild-type subunits. So when Y is present, any wild-type subunits would pair with Y, making a dimer that can't function. So the transactivation doesn't happen, no gene expression.\n\nSo the effect is that the transcription factor can't function because the dimerization is impaired, leading to loss of function. \n\nLooking back at the options, which one fits this? Let's see:\n\nOption D says protein aggregation and loss. If Y causes the proteins to aggregate, then they're not functional, so the phenotype is loss.\n\nOption B says protein degradation. I'm not sure if Y would lead to degradation. It could, but I think dominant-negative often doesn't destroy the protein but stops it from working, perhaps by causing misfolding or improper interactions.",
          "score": 0.9446625113487244
        }
      ],
      "num_detected": 14,
      "num_same_answer": 14,
      "same_answer_perc": 100.0
    },
    "0.95": {
      "detected_pairs": [
        {
          "chain1_id": "q158_c1",
          "chain2_id": "q158_c5",
          "thought1_idx": 12,
          "thought2_idx": 2,
          "text1": "Wait, option C says loss of dimerization and wild-type phenotype. That doesn't make sense. If dimerization is lost, the phenotype can't be wild-type. So that's not correct.\n\nSo, back to the options.\n\nThe Y mutation is in the dimerization domain and is dominant-negative. So the mutant subunits would interfere with the wild-type's ability to dimerize.\n\nIn a heterozygous state, there are some wild-type and some mutant proteins.\n\nWhen the mutant proteins are present, they might form non-functional dimers with the wild-type, or perhaps prevent the wild-type from finding a partner to dimerize with.\n\nSo, the wild-type protein's ability to dimerize is blocked, so the transcription factor can't function. Thus, the phenotype is a loss of function.\n\nLooking at the options, which have a loss of function.\n\nOption B: protein degradation and loss of wild-type function.\n\nOption D: protein aggregation and loss.\n\nBut I think in dominant-negative, the proteins are present but non-functional. So no degradation, but they can't form functional dimers.\n\nSo perhaps the molecular phenotype is that the proteins can't dimerize, leading to loss of function.\n\nSo, looking for an option that says loss of dimerization and loss of function. But none of the options directly state that.",
          "text2": "Wait, going back. Let's think about dominant-negative mutations. In this case, the mutant Y would form a non-functional dimer when paired with wild-type. Because the dimerization domain is messed up, they can't form active dimers. So the Y mutant prevents the wild-type from functioning. So in a heterozygote, the wild-type allele is expressed but can't form active dimers because it's either binding to the mutant Y or the mutant Y is preventing the proper folding.\n\nSo the presence of Y leads to the inability of the transcription factor to dimerize, which means it can't enter the nucleus and activate gene transcription. So the phenotype would be a loss-of-function.\n\nLooking at the options, I think D says protein aggregation and loss of function. Or B says protein degradation. But I'm not sure.",
          "score": 0.9505887627601624
        }
      ],
      "num_detected": 1,
      "num_same_answer": 1,
      "same_answer_perc": 100.0
    }
  }
}